10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

o QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For quarterly period ended May 31, 2013

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to___________

Commission file number 333-127953

NEW ENERGY TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

Nevada	59-3509694
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)
9192 Red Branch Road, Suite 110
Columbia, Maryland	21045
(Address of principal executive offices)	(Zip Code)

(800) 213-0689

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x  No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x  No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	o	Accelerated filer	o
Non-accelerated filer (Do not check if a smaller reporting company)	o	Smaller reporting company	x

Indicate by check mark whether the registrant is a shell company (as defined in 12b-2 of the Exchange Act.) Yes o No x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 24,194,713 shares of common stock, par value $0.001, were outstanding on July 15, 2013.

NEW ENERGY TECHNOLOGIES, INC.

FORM 10-Q

For the Quarterly Period Ended May 31, 2013

Table of Contents

PART I FINANCIAL INFORMATION
Item 1.	Consolidated Financial Statements (Unaudited)
	Consolidated Balance Sheets	3
	Consolidated Statements of Operations	4
	Consolidated Statements of Stockholders’ Equity (Deficit)	5
	Consolidated Statements of Cash Flows	7
	Notes to Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	17
Item 4.	Controls and Procedures	22
PART II OTHER INFORMATION
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	23
Item 6.	Exhibits	23
Signatures		24
Certifications

2

PART I — FINANCIAL INFORMATION

Item 1. Consolidated Financial Statements (Unaudited)

NEW ENERGY TECHNOLOGIES, INC.
(A Development Stage Company)
CONSOLIDATED BALANCE SHEETS
MAY 31, 2013 AND AUGUST 31, 2012
	May 31,			August 31,
	2013			2012
ASSETS	(Unaudited)
Current assets
Cash and cash equivalents	$	715,835		$	1,046,918
Deferred research and development costs		150,000			32,595
Prepaid expenses and other current assets		22,757			28,233
Total current assets		888,592			1,107,746
Equipment, net of accumulated depreciation of $10,489 and $5,882, respectively		15,359			19,966
Total assets	$	903,951		$	1,127,712
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable	$	35,643		$	63,403
Accrued liabilities		-			26,231
Convertible promissory note, net of discount of $0 and $999,485, respectively		-			515
Total current liabilities		35,643			90,149
Commitments and contingencies
Stockholders' equity
Preferred stock: $0.10 par value; 1,000,000 shares authorized, no shares issued and outstanding at May 31, 2013 and August 31, 2012		-			-
Common stock: $0.001 par value; 300,000,000 shares authorized, 24,194,713 and 20,638,360 shares issued and outstanding at May 31, 2013 and August 31, 2012, respectively		24,194			20,638
Additional paid-in capital		17,391,534			13,798,282
Deficit accumulated during the development stage		(16,547,420	)		(12,781,357	)
Total stockholders' equity		868,308			1,037,563
Total liabilities and stockholders' equity	$	903,951		$	1,127,712

(The accompanying notes are an integral part of these consolidated financial statements)

3

NEW ENERGY TECHNOLOGIES, INC.
(A Development Stage Company)
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
FOR THE THREE AND NINE MONTHS ENDED MAY 31, 2013 AND 2012 AND FOR THE
PERIOD FROM INCEPTION (MAY 5, 1998) TO MAY 31, 2013
													Cumulative
													May 5, 1998
	Three Months Ended May 31,						Nine Months Ended May 31,						(Inception) to
	2013			2012			2013			2012			May 31, 2013
Revenue	$	-		$	-		$	-		$	-		$	-
Operating expense
Selling, general and administrative		468,166			386,653			2,511,763			1,315,655			13,897,755
Research and development		115,813			241,652			224,490			557,400			2,814,628
Total operating expense		583,979			628,305			2,736,253			1,873,055			16,712,383
Loss from operations		(583,979	)		(628,305	)		(2,736,253	)		(1,873,055	)		(16,712,383	)
Other income (expense)
Interest income		-			-			-			-			98,582
Interest expense - other		-			(8,438	)		(30,325	)		(8,438	)		(68,949	)
Interest expense - accretion of debt discount		-			(15	)		(999,485	)		(15	)		(1,000,000	)
Loss on disposal of fixed assets		-			-			-			-			(5,307	)
Gain on dissolution of foreign subsidiary		-			-			-			-			59,704
Foreign exchange loss		-			-			-			(65	)		(86,428	)
Change in fair value of warrant liability		-			-			-			-			2,128,331
Payable written off		-			-			-			156,109			186,109
Total other income (expense)		-			(8,453	)		(1,029,810	)		147,591			1,312,042
Loss from continuing operations		(583,979	)		(636,758	)		(3,766,063	)		(1,725,464	)		(15,400,341	)
Loss from discontinued operations		-			(3,000	)		-			(242,210	)		(404,307	)
Net loss	$	(583,979	)	$	(639,758	)	$	(3,766,063	)	$	(1,967,674	)	$	(15,804,648	)
Basic and Diluted Loss per Common Share:
Continuing operations	$	(0.02	)	$	(0.03	)	$	(0.17	)	$	(0.08	)
Discontinued operations	$	-		$	-		$	-		$	(0.01	)
Total	$	(0.02	)	$	(0.03	)	$	(0.17	)	$	(0.10	)
Weighted average number of common shares outstanding - basic and diluted		24,174,652			20,638,360			22,174,541			20,638,360

(The accompanying notes are an integral part of these consolidated financial statements)

4

NEW ENERGY TECHNOLOGIES, INC.
(A Development Stage Company)
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)(Unaudited)
FROM MAY 5, 1998 (INCEPTION) TO MAY 31, 2013
							Deficit Accumulated
	Common Stock				Additional		During the Development			Total Stockholders'
	Shares		Amount		Paid-in Capital		Stage			Equity (Deficit)
Restricted common stock issued to related parties for management services at $0.001 per share		3,000,000	$	3,000	$	-	$	-		$	3,000
Unrestricted common stock sales to third parties at $0.40 per share		375,000		375		149,625		-			150,000
Net loss for the year ended August 31, 1998								(12,326	)		(12,326	)
Balance, August 31, 1998		3,375,000		3,375		149,625		(12,326	)		140,674
Net loss for the year ended August 31, 1999								(77,946	)		(77,946	)
Balance, August 31, 1999		3,375,000		3,375		149,625		(90,272	)		62,728
Net loss for the year ended August 31, 2000								(12,446	)		(12,446	)
Balance, August 31, 2000		3,375,000		3,375		149,625		(102,718	)		50,282
Net loss for year ended August 31, 2001								(12,904	)		(12,904	)
Balance, August 31, 2001		3,375,000		3,375		149,625		(115,622	)		37,378
Net loss for the year ended August 31, 2002								(54,935	)		(54,935	)
Balance, August 31, 2002		3,375,000		3,375		149,625		(170,557	)		(17,557	)
Restricted common stock issued at $.001 per share to two related parties to satisfy outstanding management fees.		10,333,200		10,333		92,999		-			103,332
Net loss for the year ended August 31, 2003								(97,662	)		(97,662	)
Balance, August 31, 2003		13,708,200		13,708		242,624		(268,219	)		(11,887	)
Net loss for the year ended August 31, 2004								(19,787	)		(19,787	)
Balance, August 31, 2004		13,708,200		13,708		242,624		(288,006	)		(31,674	)
Net loss for the year ended August 31, 2005								(103,142	)		(103,142	)
Balance, August 31, 2005		13,708,200		13,708		242,624		(391,148	)		(134,816	)
Issuance of common stock and warrants at $0.50 per share		1,000,000		1,000		499,000		-			500,000
Net loss for the year ended August 31, 2006								(157,982	)		(157,982	)
Balance, August 31, 2006		14,708,200		14,708		741,624		(549,130	)		207,202
Exercise of Class A Warrants  at $0.50 per share		1,000,000		1,000		499,000		-			500,000
Exercise of Class B Warrants  at $0.55 per share		1,000,000		1,000		549,000		-			550,000
Exercise of Class C Warrants  at $1.50 per share		326,667		327		489,673		-			490,000
Exercise of Class D Warrants  at $1.65 per share		293,333		293		483,707		-			484,000
Exercise of Class E Warrants  at $1.80 per share		293,333		293		527,707		-			528,000
Issuance of common stock and warrants at $1.50 per share		333,333		333		499,667		-			500,000
Dividend paid - spin off of MircoChannel Technologies Corporation		-		-		-		(400,000	)		(400,000	)
Net loss for the year ended August 31, 2007								(1,442,769	)		(1,442,769	)
Balance, August 31, 2007		17,954,866		17,955		3,790,377		(2,391,899	)		1,416,433
Common stock and warrants issued for cash and services at $3.00 per Unit		1,225,000		1,225		3,394,730		-			3,395,955
Exercise of Class C Warrants  at $1.50 per share		6,667		7		9,993		-			10,000
Exercise of Class D Warrants  at $1.65 per share		6,667		7		10,993		-			11,000
Exercise of Class F Warrants  at $3.75 per share		58,333		58		218,692		-			218,750
Stock based compensation		-		-		3,600,303		-			3,600,303
Net loss for the year ended August 31, 2008								(5,721,545	)		(5,721,545	)
Balance, August 31, 2008		19,251,533		19,251		11,025,089		(8,113,444	)		2,930,896

5

NEW ENERGY TECHNOLOGIES, INC.
(A Development Stage Company)
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)(Unaudited)
FROM MAY 5, 1998 (INCEPTION) TO MAY 31, 2013
	Common Stock					Additional			Deficit Accumulated During the Development			Total Stockholders'
	Shares			Amount		Paid-in Capital			Stage			Equity (Deficit)
Exercise of Class E Warrants  at $1.80 per share		6,667			7		11,993			-			12,000
Exercise of Class F Warrants  at $3.75 per share		275,333			275		1,032,225			-			1,032,500
Stock based compensation		-			-		183,312			-			183,312
Reversal of stock based compensation due to forfeiture of stock options		-			-		(3,591,093	)		-			(3,591,093	)
Net loss for the year ended August 31, 2009										1,961,175			1,961,175
Balance, August 31, 2009		19,533,533			19,533		8,661,526			(6,152,269	)		2,528,790
Stock based compensation		-			-		661,040			-			661,040
Reversal of stock based compensation due to forfeiture of stock options		-			-		(478,971	)		-			(478,971	)
Cumulative adjustment upon adoption of ASC 815-40		-			-		(1,785,560	)		(342,771	)		(2,128,331	)
Net loss for the year ended August 31, 2010										(233,136	)		(233,136	)
Balance, August 31, 2010		19,533,533			19,533		7,058,035			(6,728,176	)		349,392
Rounding due to reverse one for three stock split effective March 16, 2011		(3	)		-		-			-			-
Exercise of Class F Warrants at $3.75 per share		1,054,512			1,055		3,953,320			-			3,954,375
Exercise of stock options		50,318			50		30,750			-			30,800
Stock based compensation		-			-		2,855,630			-			2,855,630
Reversal of stock based compensation due to forfeiture of stock options		-			-		(1,304,551	)		-			(1,304,551	)
Net loss for the year ended August 31, 2011										(3,619,750	)		(3,619,750	)
Balance, August 31, 2011		20,638,360			20,638		12,593,184			(10,347,926	)		2,265,896
Stock based compensation		-			-		237,046			-			237,046
Reversal of stock based compensation due to forfeiture of stock options		-			-		(31,948	)		-			(31,948	)
Discount on convertible promissory note due to detachable warrants		-			-		547,050			-			547,050
Discount on convertible promissory note due to beneficial conversion feature		-			-		452,950			-			452,950
Net loss for the year ended August 31, 2012										(2,433,431	)		(2,433,431	)
Balance, August 31, 2012		20,638,360			20,638		13,798,282			(12,781,357	)		1,037,563
Stock based compensation		-			-		284,806			-			284,806
Reversal of stock based compensation due to forfeiture of stock options		-			-		(10,075	)		-			(10,075	)
Issuance of common stock and warrants at $0.64 per unit		1,875,000			1,875		1,198,125			-			1,200,000
Issuance of common stock upon the conversion of note at $0.64 per share		1,650,869			1,651		1,054,905			-			1,056,556
Exercise of stock options		22,672			22		(22	)		-			-
Issuance of common stock upon the exercise of Series H Warrants		7,812			8		6,475			-			6,483
Expense related to issuance of Series H Warrants as inducement to convert the 2012 Promissory Note		-			-		1,059,038			-			1,059,038
Net loss for the nine months ended May 31, 2013										(3,766,063	)		(3,766,063	)
Balance, May 31, 2013		24,194,713		$	24,194	$	17,391,534		$	(16,547,420	)	$	868,308

(The accompanying notes are an integral part of these consolidated financial statements)

6

NEW ENERGY TECHNOLOGIES, INC.
(A Development Stage Company)
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
FOR THE NINE MONTHS ENDED MAY 31, 2013 AND 2012 AND FOR THE
PERIOD FROM INCEPTION (MAY 5, 1998) TO MAY 31, 2013
							Cumulative
	Nine Months Ended						May 5, 1998
	May 31,						(Inception) to
	2013			2012			May 31, 2013
Cash flows from operating activities
Loss from continuing operations	$	(3,766,063	)	$	(1,725,464	)	$	(15,400,342	)
Add: loss from discontinued operations		-			(242,210	)		(404,307	)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation		4,607			3,883			14,971
Stock based compensation expense		284,806			193,185			7,822,137
Reversal of stock based compensation expense due to forfeiture of stock options		(10,075	)		(8,243	)		(5,416,638	)
Warrants issued to note holder		1,059,038			-			1,059,038
Change in fair value of warrant liability		-			-			(2,128,331	)
Loss on disposal of fixed assets		-			-			5,307
Payable written off		-			(156,109	)		(186,109	)
Common stock issued for services		-			-			3,000
Common stock issued for debt settlement		-			-			103,332
Accretion of debt discount		999,485			15			1,000,000
Changes in operating assets and liabilities:
Decrease (increase) in deferred research and development costs		(117,405	)		70,017			(150,000	)
Decrease (increase) in prepaid expenses and other current assets		5,476			53,882			(22,757	)
Increase (decrease) in accounts payable		(27,760	)		28,608			65,643
Increase (decrease) in accrued liabilities		30,325			3,538			212,665
Net cash used in operating activities		(1,537,566	)		(1,778,898	)		(13,422,391	)
Cash flows from investing activity
Purchase of equipment		-			(24,458	)		(35,637	)
Net cash used in investing activity		-			(24,458	)		(35,637	)
Cash flows from financing activities
Proceeds from the issuance of common stock, exercise of warrants and stock options, net		1,206,483			-			13,573,863
Repayment of promissory note		-			-			(155,000	)
Proceeds from promissory notes		-			1,000,000			1,155,000
Dividend paid		-			-			(400,000	)
Net cash provided by financing activities		1,206,483			1,000,000			14,173,863
Increase (decrease) in cash and cash equivalents		(331,083	)		(803,356	)		715,835
Cash and cash equivalents at beginning of period		1,046,918			2,320,185			-
Cash and cash equivalents at end of period	$	715,835		$	1,516,829		$	715,835
Supplemental disclosure of cash flow information:
Interest paid in cash	$	-		$	-		$	12,393
Income taxes paid in cash	$	-		$	-		$	-
Supplemental disclosure of non-cash transactions:
Accrued management fees converted to equity	$	-		$	-		$	103,332
Debt discount recorded for value of warrants issued	$	-		$	547,050		$	547,050
Debt discount recorded for beneficial conversion feature	$	-		$	452,950		$	452,950
Warrants issued for broker commissions	$	-		$	-		$	642,980
Common stock issued for conversion of note payable	$	1,056,556		$	-		$	1,056,556

(The accompanying notes are an integral part of these consolidated financial statements)

7

NEW ENERGY TECHNOLOGIES, INC.

(A Development Stage Company)

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 - Organization and Going Concern

Basis of Presentation

The unaudited financial statements of New Energy Technologies, Inc. as of May 31, 2013, and for the three and nine months ended May 31, 2013 and 2012, have been prepared in accordance with accounting principles generally accepted in the United States for interim financial reporting. Accordingly, they do not include all of the disclosures required by accounting principles generally accepted in the United States for complete financial statements and should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended August 31, 2012, as filed with the Securities and Exchange Commission as part of the Company’s Form 10-K. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of the interim financial information have been included. The results of operations for any interim period are not necessarily indicative of the results of operations for the entire year.

Organization

New Energy Technologies, Inc. (the “Company”) was incorporated in the State of Nevada on May 5, 1998, under the name “Octillion Corp.” On December 2, 2008, the Company amended its Articles of Incorporation to effect a change of name to New Energy Technologies, Inc. The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Sungen Energy, Inc. (“Sungen”), Kinetic Energy Corporation (“KEC”), and New Energy Solar Corporation (“New Energy Solar”).

Sungen was incorporated on July 11, 2006, in the State of Nevada and is currently inactive.

KEC was incorporated on June 19, 2008, in the State of Nevada and holds the patents related to the Company’s MotionPower™ Technology. The Company’s business activities related to the MotionPower™ Technology are conducted through KEC.

New Energy Solar was incorporated on February 9, 2009, in the State of Florida and has entered into agreements with the University of South Florida Research Foundation, Inc. to sponsor research related to the Company’s SolarWindow™ Technology.

On March 16, 2011, pursuant to a consent signed by the Company’s shareholders owning more than 50% of the Company’s issued and outstanding shares of common stock, the Company filed a Certificate of Amendment to its Certificate of Incorporation increasing its authorized shares of common stock, $0.001 par value, from 100,000,000 to 300,000,000.

On August 19, 2011, the Company established Nakoda Energy, Inc., a California corporation and wholly-owned subsidiary of the Company, which began operations in September 2011. Nakoda is an energy savings and management corporation that provides a broad range of energy solutions and savings projects with the goal of implementing energy conservation, load management, and reducing building energy consumption in target markets. Due to the high costs associated with growing operations and difficult financing environment, management suspended all Nakoda related operations as of November 30, 2011. On January 20, 2012, management completed the sale of Nakoda Energy, Inc. pursuant to a stock purchase agreement. The Company did not recognize any revenue from Nakoda related operations nor were there any recorded assets or liabilities as of and during the periods presented.

The Company is a renewable and alternative energy company, actively developing two novel technologies for generating sustainable electricity, one of which collects light energy from the sun and artificial sources (SolarWindow™), and the other harvests kinetic energy present in moving vehicles (MotionPower™). The Company’s proprietary, patent-pending technologies and products, which are the subjects of sixty-six (66) patent-filings, have been invented, designed, engineered, and prototyped in preparation for further field testing, product development, and eventual commercial deployment.

8

The Company’s SolarWindow™ Technology generates electrical energy when the electricity-generating coating is applied to glass and plastic surfaces, creating, semi-transparent, see-through solar cells. If successfully developed, SolarWindow™ could potentially be used on any of the more than 85 million commercial and residential buildings in the United States alone (U.S. Census Bureau, 2007 American Housing Survey & U.S. Energy Information Administration, 2003 Commercial Buildings Energy Consumption Survey). The Company has filed seven (7) new Patent related to the SolarWindow™ Technology since our last 10-Q filing. The Company’s SolarWindow™ Technology is the subject of a total of twenty-one (21) patent filings.

The Company’s MotionPower™ Technology harvests, or captures, the “kinetic” or “motion” energy of cars, trucks, buses, and heavy commercial vehicles when they pass over the system or slow down before coming to a stop. MotionPower™ converts this captured energy into electricity. If successfully developed, MotionPower™ could potentially be used to harvest kinetic energy generated by any of the estimated 250 million vehicles registered in America (U.S. Department of Transportation Federal Highway Administration, 2008 Highway Statistics), which drive approximately six billion miles on our nation’s roadways every day (U.S. Environmental Protection Agency). The Company’s MotionPower™ Technology is the subject of forty-five (45) patent filings.

The Company’s product development programs involve ongoing research and development efforts, and the commitment of significant resources to support the extensive invention, design, engineering, testing, prototyping, and intellectual property initiatives carried-out by its contract engineers, scientists, and consultants.

The Company continues to assess the ongoing development and value propositions of its novel SolarWindow™ and MotionPower™ technologies. This assessment helps us strategically focus on specific technology development which best delivers significant long-term commercial competitive advantages.

Going Concern

The Company is a development stage company, does not have any commercialized products and has not generated any revenue since inception. The Company has an accumulated deficit of $16,547,420 as of May 31, 2013, and does not have positive cash flows from operating activities. Included in the deficit are non cash expenses totaling $4,570,869 relating to the issuance of stock for services, compensatory stock options, warrants granted for value and accretion of debt discount. The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America, which contemplates continuation of the Company as a going concern, which is dependent upon the Company’s ability to establish itself as a profitable business.

In its report with respect to the Company’s financial statements for the year ended August 31, 2012, the Company’s independent auditors expressed substantial doubt about the Company’s ability to continue as a going concern. Because the Company has not yet generated revenues from its operations and does not expect to do so in the near future, its ability to continue as a going concern is wholly dependent upon its ability to obtain additional financing.

On February 1, 2013, the Company received $1,200,000 from an equity financing through the sale of its securities. As of May 31, 2013, the Company had cash and cash equivalents of $715,835. The Company will remain engaged in research and product development activities at least through January 2015. Based upon its current and near term anticipated level of operations and expenditures, the Company believes that, absent any modification or expansion of its existing research, development and testing activities, cash on hand should be sufficient to enable it to continue operations through October 2013. However, any significant expansion in scope or acceleration in timing of the Company’s current research and development activities, or commencement of any marketing, and public and investor relations activities, will require additional funds.

9

If adequate funds are not available on reasonable terms, or at all, it would result in a material adverse effect on the Company’s business, operating results, financial condition and prospects. In particular, the Company may be required to delay, reduce the scope of or terminate one or more of its research programs, sell rights to its SolarWindow™ Technology and/or MotionPowerTM Technology or other technologies or products based upon such technologies, or license the rights to such technologies or products on terms that are less favorable to the Company than might otherwise be available.

In view of these conditions, the ability of the Company to continue as a going concern is in substantial doubt and dependent upon achieving a profitable level of operations and on the ability of the Company to obtain necessary financing to fund ongoing operations. These consolidated financial statements do not give effect to any adjustments which will be necessary should the Company be unable to continue as a going concern and therefore be required to realize its assets and discharge its liabilities in other than the normal course of business and at amounts different from those reflected in the accompanying consolidated financial statements.

NOTE 2 - Convertible Promissory Note

On April 17, 2012, the Company entered into a Bridge Loan Agreement (the “Loan Agreement”) with 1420524 Alberta Ltd. (the “Creditor”), pursuant to which the Company borrowed $1,000,000 at an annual interest rate of 7% (the “Loan”), compounded quarterly; following the occurrence of an event of default, as further specified in the Loan Agreement, the annual interest rate would increase to 15%. The Loan was evidenced by a convertible promissory note with a maturity date of the earlier of: (a) the closing of any equity financing by the Company in excess of $1,000,000, or (b) April 16, 2013 (the “2012 Promissory Note”). As a condition to the Creditor’s entry into the Loan Agreement, the Company issued the Creditor 625,000 Series G Stock Purchase Warrants (the “Series G Warrants”), which are exercisable through April 17, 2015, with an initial exercise price of 84% of the average of the closing price for our common stock as reported on the OTC Markets Group Inc. QB tier (the “OTCQB”) for the five trading days immediately preceding the closing of the Loan, or $1.92 per share, subject to adjustment as provided therein. Additionally, the Series G Warrants contain a cashless exercise provision and require us to file a registration statement with the SEC for the shares issuable upon exercise of the Series G Warrants within 60 days receipt of a written request by the Creditor. According to the original terms of the Loan Agreement, the Creditor could elect, in its sole discretion, to convert all or any portion of the outstanding principal amount of the Loan, and any or all accrued and unpaid interest thereon into shares of our common stock at an initial fixed conversion price equal to seventy (70%) percent of the average of the closing price for the Company’s common stock as reported on the OTCQB for the five trading days immediately preceding the closing of the Loan, or $1.60 per share subject to adjustment as provided therein. The debt discount attributable to the relative fair value of the warrants and the beneficial conversion feature amounted to $547,050 and $452,950, respectively, and was to be accreted over the term of the Loan using the effective interest method.

On February 1, 2013, the Company and the Creditor entered into a Loan Conversion Agreement (“LCA”) whereby the Creditor agreed to convert the entire balance outstanding, including $1,000,000 of principal and $56,556 of accrued interest payable into 1,650,869 shares of restricted common stock. In order to induce the Creditor to convert the Loan into shares of common stock, and eliminate the Company’s obligation to repay the Loan in cash, the effective conversion price was reduced to $0.64 (the price at which the Company sold shares pursuant to its self-directed registered offering; see “NOTE 3 – Stockholders’ Equity (Deficit)” below) from the initial conversion price of $1.60. In addition, as an inducement to convert, the Company issued to the Creditor 825,435 Series H Warrants and reduced the exercise price of the Series G Warrants to $0.64 (See “NOTE 3 – Stockholders’ Equity (Deficit)” below for additional information). No incremental expense was recognized in these consolidated financial statements related to the reduction in the exercise price of the Series G Warrants, and the conversion of the Loan, because the transaction did not meet the requirements for an inducement under accounting principles generally accepted in the United States. As such, the Loan conversion was accounted for as a debt extinguishment with no gain or loss recognized due to the related party nature of the transaction. The Company recognized expense amounting to $1,059,038 for the issuance of the Series H warrants to the Creditor, representing additional financing costs associated with the Loan.

10

During the three and nine months ended May 31, 2013, the Company recognized $0 and $30,325, respectively, of interest expense related to the 2012 Promissory Note. During the three and nine months ended May 31, 2012, the Company recognized $8,438 of interest expense related to the 2012 Promissory Note.

During the three and nine months ended May 31, 2013, the Company recognized $0 and $999,485, respectively, of accretion related to the Loan discount. As a result of the Loan conversion, the debt discount was fully amortized by February 1, 2013, the date of the LCA.

NOTE 3 – Stockholders’ Equity (Deficit)

On February 1, 2013, in full satisfaction of the 2012 Promissory Note, the Company issued to the Creditor 1,650,869 shares of restricted common stock upon the conversion of the 2012 Promissory Note, as adjusted in accordance with the terms of the LCA. Additionally, pursuant to the terms of the LCA, the Company issued to the Creditor 825,435 Series H Warrants and reduced the exercise price of the Series G Warrants to $0.64 (See “Note 2 - Convertible Promissory Note” above for additional information).

On February 1, 2013, the Company completed a self-directed registered offering of 1,875,000 units at a price of $0.64 per unit for $1,200,000 in aggregate proceeds (the “Registered Offering”). Each unit consisted of one share of the Company’s common stock and one-half Series H stock purchase warrant (“Series H Warrant”) to purchase one-half of a share of common stock at the initial exercise price of $0.83 per share for a period of three years from the date of issuance. The Company issued 937,503 Series H Warrants as part of the Registered Offering. The relative fair value of the common stock was estimated to be $638,717 and the relative fair value of the warrants was estimated to be $561,283 as determined based on the relative fair value allocation of the proceeds received. The Series H Warrants were valued using the Black-Scholes option pricing model using the following variables: $0.83 exercise price, $1.48 stock price, 161% volatility, 0.40% risk-free interest rate, 3 year term and no dividends.

On March 21, 2013, the Company issued 7,812 shares of common stock upon the exercise of an equal number of Series H Warrants and received proceeds of $6,484.

Warrants

Each of the Company’s warrants outstanding entitle the holder to purchase one share of the Company’s common stock for each warrant share held. A summary of the Company’s warrants outstanding and exercisable as of May 31, 2013 and August 31, 2012 is as follows:

	Shares of Common Stock Issuable from Warrants Outstanding as of
Description	May 31, 2013		August 31, 2012		Exercise Price		Expiration
Series G		625,000		625,000	$	0.64	April 17, 2015
Series H		1,755,126		-	$	0.83	February 1, 2016
		2,380,126		625,000

The Series G Warrants were issued on April 17, 2012 as a condition to the Creditor entering into the Loan Agreement more fully described above under “Note 2 - Convertible Promissory Note.” In order to induce the Creditor to convert the Loan into shares of the Company’s common stock, the initial exercise price of $1.92 was reduced to $0.64. Additionally, the Series G Warrants contain a cashless exercise provision and registration rights requiring us to file a registration statement with the SEC for the shares issuable upon exercise of the Series G Warrants within 60 days receipt of a written request by the Creditor.

11

As inducement to convert the Loan, on February 1, 2013, the Company issued to the Creditor 825,435 Series H Warrants (See “Note 2 - Convertible Promissory Note” above for additional information). The warrants have an exercise price of $0.83 per share, expire on the third anniversary of the LCA, or on February 1, 2016 and may be exercised in whole or in part at any time from the date of issuance through expiration. Based on the following Black-Scholes Option Pricing Model assumptions: exercise price - $0.83; market price of common stock - $1.48 per share; estimated volatility - 161%; risk free interest rate - 0.40%; expected dividend rate - 0%; and expected life - 3.0 years, the Company calculated the fair value of these warrants to be $1,059,038.

On February 1, 2013, as part of the Registered Offering, the Company issued 937,503 Series H Warrants (See “Note 3 – Stockholders’ Equity (Deficit)” above for additional information).

During the three and nine months ended May 31, 2013, the Company received $6,484 upon the exercise of 7,812 Series H warrants by two warrant holders.

NOTE 4 - Stock Options

On October 10, 2006, the Company’s Board of Directors (the “Board”) adopted and approved the 2006 Incentive Stock Option Plan (the “2006 Stock Plan”) that provides for the grant of stock options to employees, directors, officers and consultants. Stock option grants vest over two to five years and expire ten years after the date of grant. Stockholders previously approved 5,000,000 shares for grant under the 2006 Plan, of which 3,892,495remain available for grant and 136,667 options have been exercised as of May 31, 2013. All shares approved for grant and subsequently forfeited are available for future grant. The Company does not repurchase shares to fulfill the requirements of options that are exercised. The Company issues new shares when options are exercised.

The Company measures all stock-based compensation based on the fair value on the grant date using the Black-Scholes-Merton formula and recognizes expense over the requisite service period. The Black-Scholes model requires management to make assumptions regarding option time to expiration, expected volatility, and risk-free interest rates, all of which have a significant impact on the fair value of the option.

The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for a bond with a similar term. The Company does not anticipate declaring dividends in the foreseeable future. Volatility is calculated based on the historical closing stock prices. The Company uses the “simplified” method for determining the expected term of its “plain vanilla” stock options. The Company recognizes compensation expense for only the portion of stock options that are expected to vest. Therefore, the Company applies an estimated forfeiture rate that is derived from historical employee termination data and adjusted for expected future employee turnover rates. If the actual number of forfeitures differs from those estimated by the Company, additional adjustments to compensation expense may be required in future periods.

A summary of the Company’s stock option activity for the nine months ended May 31, 2013 and the years ended August 31, 2012 and 2011, and related information follows:

	Number of Options			Weighted Average Exercise Price ($)		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value ($)
Outstanding at August 31, 2010		900,003			1.71
Grants		610,002			5.97
Exercises		(73,334	)		1.61
Forfeitures		(476,666	)		5.59
Outstanding at August 31, 2011		960,005			2.49
Forfeitures		(98,334	)		5.93
Outstanding at August 31, 2012		861,671			2.10
Grants		177,500			1.59
Exercises		(63,333	)		1.65
Forfeitures		(5,000	)		3.27
Outstanding at May 31, 2013		970,838			2.03	7.09 years	$	410,284
Exercisable at May 31, 2013		446,004			2.48	6.47 years	$	164,326
Available for grant at May 31, 2013		3,892,495

12

The aggregate intrinsic value in the table above represents the total pretax intrinsic value for all “in-the-money” options (i.e. the difference between the Company’s closing stock price on the last trading day of the period covered by this report and the exercise price, multiplied by the number of shares) that would have been received by the option holders had all in-the-money option holders exercised their options on May 31, 2013. The intrinsic value of the option changes based upon the fair market value of the Company’s common stock. Since the closing stock price was $2.11 on May 31, 2013 and 828,335 outstanding options have an exercise price below $2.11 per share, as of May 31, 2013, there is intrinsic value to our outstanding in-the-money stock options.

The following table sets forth the share-based compensation cost resulting from stock option grants, including those previously granted and vesting over time, that were recorded in the Company’s Consolidated Statements of Operations for the three and nine months ended May 31, 2013 and 2012, and from May 5, 1998 (inception) to May 31, 2013:

	Three Months Ended				Nine Months Ended				May 5, 1998
	May 31,				May 31,				(Inception) to
	2013		2012		2013		2012		May 31, 2013
Stock Compensation Expense net of reversals:
Selling general and administrative expense	$	51,165	$	48,272	$	274,731	$	184,942	$	2,405,499

As of May 31, 2013, the Company had $116,828 of unrecognized compensation cost related to unvested stock options which is expected to be recognized over a period of 2.25 years.

Stock Option Activity During the Nine Months Ended May 31, 2013

On December 20, 2012, the Company granted two stock options to purchase up to 15,000 (a 10,000 and 5,000 option grant, respectively) shares of the Company’s common stock at an exercise price of $0.80 per share, the fair market value of the Company’s common stock on the date of grant, to two employees as partial compensation for services. The stock options expire ten years from the date of grant, on December 20, 2022 and vest as follows: (a) 7,500 shares vest immediately on the date of grant and (b) 7,500 shares on the one-year anniversary on December 20, 2013. The stock options are further subject to the terms and conditions of a stock option agreement between the Company and the employees. Under the terms of the stock option agreement, the stock option agreement will terminate and there will be no further vesting of stock options effective as of the date that employees cease to be one of the Company’s employees. Upon termination of such service, the employee will have a specified period of time to exercise vested stock options, if any. The grant date fair value of the stock option granted was $11,700, or $0.78 per option, estimated using the Black-Scholes model containing the following assumptions: Exercise price / spot price of $0.80 per share, dividend yield of 0%, volatility of 160.1%, risk-free rate of 1.14%, and a term of 7.67 years. During the three and nine months ended May 31, 2013, the Company recognized $1,463 and $8,775, respectively of expense related to these two issuances.

On April 27, 2012, pursuant to his employment agreement, the Company’s Vice President of Business and Technology Development, Mr. John Patrick Thompson received a grant of 100,000 stock options. The options have an exercise price of $2.30, the fair market value of the Company’s common stock on the date of grant. The stock options expire ten years from the date of grant, on April 27, 2022 and vest in various amounts upon the meeting of certain milestones and which vesting is subject to Board approval. The stock option is further subject to the terms and conditions of a stock option agreement between the Company and the employee. Under the terms of the stock option agreement, the stock option agreement will terminate and there will be no further vesting of stock options effective as of the date the employee ceases to be one of the Company’s employees. Upon termination of such service, the employee will have a specified period of time to exercise vested stock options, if any. The grant date fair value of the stock option granted was $225,000, or $2.25 per option, estimated using the Black-Scholes model containing the following assumptions: Exercise price / spot price of $2.30 per share, dividend yield of 0%, volatility of 167.1%, risk-free rate of 1.34%, and term of 7.67 years. The Company recognizes compensation cost associated with this stock option grant with performance conditions when the Company determines that it is probable that certain milestones will be achieved. On December 20, 2012, the Company’s Board determined that milestones related to 2,500 options were substantially met and during the three and nine months ended May 31, 2013, the Company recognized $5,625 of expense related to this award.

13

On January 23, 2013, the Board approved, and the Company granted, a stock option to each of the Company’s four directors, including John Conklin, CEO, to purchase 40,000 shares of its common stock at an exercise price of $1.65 per share, the fair market value of the Company’s common stock on the date of grant. Each stock option expires ten years from the date the applicable stock option agreement was executed, on January 23, 2023, and vests as follows: (a) 20,000 shares vest immediately on the date of grant and (b) 20,000 shares on the one-year anniversary on January 23, 2014. The stock options are further subject to the terms and conditions of a stock option agreement between the Company and each director. Under the terms of the stock option agreement, the stock option agreement will terminate and there will be no further vesting of stock options effective as of the date that the director ceases to be one of the Company’s directors. Upon termination of such service, the director will have a specified period of time to exercise vested stock options, if any. The grant date fair value of each of the stock options granted to each of the Company’s directors was $64,386 estimated using a Black-Scholes model containing the following assumptions: Exercise price / spot price of $1.65 per share, dividend yield of 0%, volatility of 161.1%, risk-free rate of 1.24%, and a term of 7.67 years. During the three and nine months ended May 31, 2013, the Company recognized $32,193 and $193,157 of expense related to this issuance.

On December 10, 2012, Mr. Peter Fusaro resigned from the Board. As a result of his resignation, Mr. Fusaro forfeited 5,000 unvested stock options and had vested 11,667 stock options. Total stock based compensation expense related to Mr. Fusaro’s options was $48,850 of which $44,270 was expensed through August 31, 2012. On November 30, 2012, the Company reversed $10,075 of expense related to forfeited options on which expense was previously recorded resulting in total recognized expense related to Mr. Fusaro’s options of $34,195. Mr. Fusaro has until December 10, 2014, to exercise his 11,667 vested stock options.

Stock Option Activity During the Year Ended August 31, 2012

On December 8, 2011, Mr. Todd Pitcher resigned from the Board. Mr. Pitcher had vested 6,667 stock options and forfeited 10,000 unvested stock options with an exercise price of $3.27 per share. During the year ended August 31, 2011, the Company recorded stock based compensation of $27,784 for the amortization of the fair value of his stock option. Since the stock option was forfeited prior to 10,000 options vesting, $8,243 previously recognized for stock based compensation was reversed on November 30, 2011, resulting in total stock based compensation expense related to Mr. Pitcher’s stock option grant of $19,541. Mr. Pitcher has until December 8, 2013, to exercise his 6,667 vested stock options.

On August 12, 2012, 83,334 vested options with an exercise price of $6.21 per share held by Mr. Andrew Farago, the Company’s former Chief Operating Officer expired unexercised.

On September 30, 2012, Mr. Javier Jimenez resigned from the Board. As a result of his resignation, Mr. Jimenez forfeited 5,000 unvested stock options and had vested 11,667 stock options with an exercise price of $3.27 per share. The Company recorded stock based compensation totaling $91,780 related to the amortization of the fair value of this stock option grant, including the recognition of $66,252 and $25,528 of expense for the years ended August 31, 2012 and 2011, respectively. Since the stock option was forfeited prior to 5,000 options vesting, $23,705 previously recognized for stock based compensation was reversed on August 31, 2012, resulting in total stock based compensation expense related to Mr. Jimenez’s stock option grant of $68,075. Mr. Jimenez has until September 30, 2014, to exercise his 11,667 vested stock options.

14

The following table summarizes information about stock options outstanding and exercisable at May 31, 2013:

		Stock Options Outstanding						Stock Options Exercisable
				Weighted		Weighted				Weighted Average		Weighted
Range of		Number of		Average		Average		Number		Remaining		Average
Exercise		Options		Contractural		Exercise		of Options		Contractual		Exercise
Prices		Outstanding		Life (years)		Price		Exercisable		Life (Years)		Price
$	0.80		15,000		9.56	$	0.80		7,500		9.56	$	0.80
	1.32		50,001		1.54		1.32		50,001		1.54		1.32
	1.65		763,334		7.07		1.65		250,000		8.61		1.65
	2.30		2,500		8.91		2.30		2,500		8.91		2.30
	2.50		10,000		7.85		2.50		6,000		7.85		2.50
	2.55		33,334		5.28		2.55		33,334		5.28		2.55
	3.27		18,334		1.16		3.27		18,334		1.16		3.27
	4.98		16,667		4.78		4.98		16,667		4.78		4.98
	5.94		50,001		7.57		5.94		50,001		7.57		5.94
	6.51		11,667		1.33		6.51		11,667		1.33		6.51
Total			970,838		7.09	$	2.03		446,004		6.47	$	2.48

NOTE 5 - Net Loss Per Share

During the three and nine months ended May 31, 2013 and 2012, the Company recorded a net loss. Basic net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. The Company has not included the effects of warrants, stock options and convertible debt on net loss per share for the past two fiscal years because to do so would be antidilutive.

Following is the computation of basic and diluted net loss per share for the three and nine months ended May 31, 2013 and 2012:

	Three Months Ended May 31,						Nine Months Ended May 31,
	2013			2012			2013			2012
Basic and Diluted EPS Computation
Numerator:
Loss available to common stockholders'	$	(583,979	)	$	(639,758	)	$	(3,766,063	)	$	(1,967,674	)
Denominator:
Weighted average number of common shares outstanding		24,174,652			20,638,360			22,174,541			20,638,360
Basic and diluted EPS	$	(0.02	)	$	(0.03	)	$	(0.17	)	$	(0.10	)
The shares listed below were not included in the computation of diluted loss
per share because to do so would have been antidilutive for the periods presented:
Warrants		2,380,126			625,000			2,380,126			625,000
Stock options		970,838			950,005			970,838			950,005

15

NOTE 6 - Related Party Transactions

A related party is generally defined as (i) any person that holds 10% or more of the Company’s securities and their immediate families, (ii) the Company’s management, (iii) someone that directly or indirectly controls, is controlled by or is under common control with the Company, or (iv) anyone who can significantly influence the financial and operating decisions of the Company. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.

For services rendered in the capacity of a Board member, non-employee Board members received $3,750 per quarter through the quarter ended February 28, 2013. The amount was increased to $4,250 per quarter beginning with the current quarter ending on May 31, 2013. New Board member compensation is pro rated in their first quarter. During the three months ended May 31, 2013 and 2012, the Company incurred $12,750 and $18,750, respectively in cash based Board compensation. During the nine months ended May 31, 2013 and 2012, the Company incurred $40,500 and $70,350, respectively in cash based Board compensation. Additionally, the Company recognized stock compensation expense related to stock options granted for services rendered by non-employee directors of the Company, which is included in professional fees (See “Note 4 - Stock Options” above) during the three months ended May 31, 2013 and 2012 of $24,983 and $19,782, respectively. During the nine months ended May 31, 2013 and 2012, the Company recognized stock compensation expense of $151,785 and $96,138, respectively.

The law firm of Sierchio & Company, LLP, of which Joseph Sierchio, one of the Company's directors, is a principal, has provided counsel to the Company since its inception. In July 2008, the Company asked Mr. Sierchio to join the Company’s Board. During the three months ended May 31, 2013 and 2012, the law firm of Sierchio & Company, LLP provided $18,550 and $44,099, respectively, of legal services. During the nine months ended May 31, 2013 and 2012, the law firm of Sierchio & Company, LLP provided $84,873 and $141,528, respectively, of legal services. At May 31, 2013, the Company owed Sierchio & Company LLP $6,225 which is included in accounts payable.

On February 1, 2013, Kalen Capital Holdings LLC, a wholly-owned subsidiary of Kalen Capital Corporation, a shareholder owning in excess of 5% of the Company’s issued and outstanding stock, purchased 1,843,748 shares of the Company’s common stock and 921,875 Series H Warrants for an aggregate purchase price of $1,180,000 pursuant to the registered public offering conducted by the Company (See “NOTE 3 – Stockholders’ Equity (Deficit)” above).

All related party transactions are recorded at the exchange amount established and agreed to between related parties and are in the normal course of business.

16

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

This Report on Form 10-Q contains forward-looking statements which involve assumptions and describe our future plans, strategies, and expectations, and are generally identifiable by use of words such as “may,” “will,” “should,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” or “project,” or the negative of these words or other variations on these words or comparable terminology. These statements are expressed in good faith and based upon a reasonable basis when made, but there can be no assurance that these expectations will be achieved or accomplished.

Such forward-looking statements include statements regarding, among other things, (a) the potential markets for our technologies, our potential profitability, and cash flows, (b) our growth strategies, (c) expectations from our ongoing research and development activities, (d) anticipated trends in the technology industry, (e) our future financing plans, and (f) our anticipated needs for working capital. This information may involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from the future results, performance, or achievements expressed or implied by any forward-looking statements. These statements may be found under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” as well as in this Form 10-Q generally. Actual events or results may differ materially from those discussed in forward-looking statements as a result of various factors, including, without limitation, the matters described in this Form 10-Q generally. In light of these risks and uncertainties, there can be no assurance that the forward-looking statements contained in this filing will in fact occur. In addition to the information expressly required to be included in this filing, we will provide such further material information, if any, as may be necessary to make the required statements, in light of the circumstances under which they are made, not misleading.

Although forward-looking statements in this report reflect the good faith judgment of our management, forward-looking statements are inherently subject to known and unknown risks, business, economic and other risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this report, other than as may be required by applicable law or regulation. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect our actual results may vary materially from those expected or projected.

Except where the context otherwise requires and for purposes of this Form 10-Q only, “we,” “us,” “our,” “Company,” “our Company,” and “New Energy” refer to New Energy Technologies, Inc., a Nevada corporation, and its consolidated subsidiaries.

Overview

We were incorporated in the State of Nevada on May 5, 1998, under the name “Octillion Corp.” On December 2, 2008, we amended our Articles of Incorporation to change our name to New Energy Technologies, Inc. The accompanying consolidated financial statements include our accounts and those of our wholly-owned subsidiaries, Sungen, KEC and New Energy Solar. Sungen was incorporated on July 11, 2006, in the State of Nevada and is currently inactive. KEC was incorporated on June 19, 2008, in the State of Nevada and holds the patents related to our MotionPower™ technology. Our business activities related to the MotionPower™ Technology are conducted through KEC.

New Energy Solar was incorporated on February 9, 2009, in the State of Florida and has entered into agreements with the University of South Florida Research Foundation, Inc. to sponsor research related to the Company’s SolarPower™ Technology. Although we are in the process of negotiating terms and conditions for a new world-wide licensing agreement for completed research and related patent filings, it is not certain when or if such a license will be finalized.

17

We are a development stage renewable and alternative energy company developing two (2) sustainable electricity generating systems. These novel technologies are branded as SolarWindow™ and MotionPower™. Our proprietary, patent-pending technologies are the subject of sixty-six (66) US and international patent filings. Our SolarWindow™ Technology provides the ability to harvest light energy from the sun and artificial sources and generate electricity from a see-through, semi-transparent, coating of OPV solar cells applied to glass and plastics. Our SolarWindow™ Technology is the subject of twenty-one (21) patent filings. Our MotionPower™ Technology, harvests “kinetic” or “motion” energy from vehicles when they slow down before coming to a stop and converts this captured energy into electricity. Our MotionPower™ Technology is the subject of forty-five (45) patent filings.

We do not currently have any commercial products and there is no assurance that we will successfully be able to design, develop, manufacture, or sell any commercial products in the future.

Our product development programs involve ongoing research and development efforts, and the commitment of significant resources to support the extensive invention, design, engineering, testing, prototyping, and intellectual property initiatives carried-out by our contract engineers, scientists, and consultants.

Ultimately, we plan to market any SolarWindow™ Technology and/or MotionPower™ Technology products through co-marketing, co-promotion, licensing and distribution arrangements with third party collaborators. We believe that this approach could provide immediate access to pre-existing distribution channels, therefore potentially increasing market penetration and commercial acceptance of our products and enabling us to avoid expending significant funds for development of a large sales and marketing organization.

We cannot accurately predict the amount of funding or the time required to successfully commercialize either the SolarWindow™ Technology or the MotionPower™ Technology. The actual cost and time required to commercialize these technologies may vary significantly depending on, among other things, the results of our research and development efforts, the cost of developing, acquiring, or licensing various enabling technologies, changes in the focus and direction of our research and development programs, competitive and technological advances, the cost of filing, prosecuting, defending and enforcing claims with respect to patents, the regulatory approval process and manufacturing, marketing and other costs associated with commercialization of these technologies. Because of this uncertainty, even if financing is available to us, we may secure insufficient funding to effectuate our business plan.

As of May 31, 2013, we had working capital of $852,949. Based upon our current level of operations and expenditures, we believe that, absent any modification or expansion of our existing research, development and testing, cash on hand should be sufficient to enable us to continue operations through at least December, 2013. However, any significant expansion in scope or acceleration in time of our current research and development activities, or commencement of any marketing activities, and public and investor relations activities will require additional funds.

Research and Related Agreements

We are a party to certain agreements related to the development of our SolarWindow™ Technology and our MotionPower™ Technology.

Stevenson-Wydler Cooperative Research and Development Agreement with the Alliance for Sustainable Energy

In efforts to advance the commercial development of the SolarWindow™ Technology, on March 18, 2011, we entered into a Stevenson-Wydler Cooperative Research and Development Agreement (the “CRADA”) with Alliance for Sustainable Energy, LLC (“Alliance”), the operator of The National Renewable Energy Laboratory (“NREL”) under its U.S. Department of Energy contract. Under terms of the CRADA, NREL researchers will make use of our exclusive intellectual property (“IP”), newly developed IP, and NREL’s background IP in order to work towards specific product development goals. Under the terms of the CRADA, we agreed to reimburse Alliance for filing fees associated with all documented, out-of-pocket costs directly related to patent application preparation and filings, and maintenance of the patent applications.

18

On January 16, 2013, we entered into a modification to the CRADA for the purpose of extending the date pursuant to which NREL’s researchers will make use of the Company’s exclusive IP and NREL’s background IP. As part of the extension, we advanced $150,000 to Alliance as a retainer, which will be used once the development goals are met. Until such time, however, Alliance bills us monthly for R&D related costs as they are incurred.

On March 6, 2013, we entered into Phase II of our CRADA with Alliance. Under the terms of the agreement, researchers will additionally work towards:

·   Further improve SolarWindow™ efficiency and transparency;

·   Optimize electrical power (current and voltage) output;

·   Optimize the application of the active layer coatings which make it possible for SolarWindow™ to generate electricity on glass surfaces;

·   Develop improved electricity-generating coatings by enhancing performance, processing, reliability, and durability;

·   Optimize SolarWindow™ performance on flexible substrates; and

·   Develop high speed and large area roll-to-roll (R2R) and sheet-to-sheet (S2S) coating methods required for commercial-scale BIPV and windows.

University of South Florida Research Foundation, Inc. License Agreement, Option Agreement and Sponsored Research Agreement

Through New Energy Solar, we are a party to a License Agreement, an Addendum to the License Agreement, an Option Agreement and a Sponsored Research Agreement with the University of South Florida Research Foundation, Inc. These agreements provide for our support of a project relating to the development of the SolarWindow™ Technology and grant us an exclusive worldwide commercial license for patents relating to the SolarWindow™ Technology developed at the University of South Florida (“USF”).

On July 5, 2011, we entered into a letter agreement pursuant to which we agreed to reimburse USF for patent application preparation and filing fees associated with USF’s patent applications (the “Applications”) for certain identified technologies (the “Letter Agreement”). Pursuant to the terms of the Letter Agreement, we committed to reimburse USF for all documented, out-of-pocket costs directly related to the filing and maintenance of the Applications. In return, USF granted us the exclusive right to negotiate a definitive option or license agreement with USF for the technologies underlying the Applications for a period of time after USF files a patent for an identified technology (the “Negotiation Period”). Should the Negotiation Period expire without us entering into an agreement with USF, we could extend the Negotiation Period for an additional period of time by paying USF a one-time payment of a specified sum. If after this additional time we fail to enter into an agreement with USF, USF is free to enter into negotiations and license the underlying technologies to a third-party. The USF Research Foundation, Inc. granted the lead USF research scientist authorization to enter into discussions with us to extend the date of the Sponsored Research Agreement. We mutually agreed with USF to terminate the sponsored research on February 23, 2013, as the scope of work of the sponsored research had been substantially comleted. We are in the process of negotiating terms to a new world-wide licensing agreement for completed research and related patent filings.

Sigma Design Agreement

Through KEC, we continues to be a party to consulting agreements with Sigma Design Company, LLC (“Sigma”) a Middlesex, New Jersey based engineering and design firm, pursuant to which Sigma provides ongoing engineering, product development and testing services primarily relating to the development of the MotionPower™ technologies.

19

Results of Operations

Three and Nine Months Ended May 31, 2013 Compared with the Three and Nine Months Ended May 31, 2012

Operating Expenses

A summary of our operating expense for the three and nine months ended May 31, 2013 and 2012 follows:

	Three Months Ended May 31,
	2013		2012		Increase / (Decrease)			Percentage Change
Operating expense
Selling, general and administrative	$	417,001	$	338,381	$	78,620			23	%
Research and development		115,813		241,652		(125,839	)		-52	%
Stock compensation		51,165		48,272		2,893			6	%
Total operating expense	$	583,979	$	628,305	$	(44,326	)		-7	%

	Nine Months Ended May 31,
	2013		2012		Increase / (Decrease)			Percentage Change
Operating expense
Selling, general and administrative	$	1,177,994	$	1,130,713	$	47,281			4	%
Research and development		224,490		557,400		(332,910	)		-60	%
Stock compensation		1,333,769		184,942		1,148,827			621	%
Total operating expense	$	2,736,253	$	1,873,055	$	863,198			46	%

Selling, General and Administrative

Selling, general and administrative (“SG&A”) costs include all expenditures incurred other than research and development related costs, including costs related to personnel, professional fees, travel and entertainment, public company costs, insurance and other office related costs. During the three months ended May 31, 2013 compared to the three months ended May 31, 2012, SG&A costs increased by $78,620 due to higher public company costs primarily related to fees paid to publicize our SolarWindow™ and MotionPower™ technologies within the industry and investor community offset by a decrease in professional fees, personnel and other general costs.

During the nine months ended May 31, 2013 compared to the nine months ended May 31, 2012, SG&A costs decreased by $991 due to higher personnel costs, travel related costs and public company costs primarily related to fees paid to publicize our SolarWindow™ and MotionPower™ technologies within the industry and investor community offset by a decrease in professional fees, patent application costs and other general costs

Stock Compensation

Stock compensation represents the expense associated with the amortization of our stock options and other equity based payments. During the nine months ended May 31, 2013, stock compensation expense increased $1,148,827 due to 1) $1,059,038 recognized upon the issuance of Series H Warrants granted as an inducement to convert the 2012 Promissory Note and accrued interest payable of $56,556 into shares of common stock and 2) the expense associated with the grant of 177,500 stock options during the nine months ended May 31, 2013 and related vesting.

20

Research and Development

Research and development (“R&D”) costs represent costs incurred to develop our SolarWindow™ and MotionPower™ technologies and are incurred pursuant to our research agreements and agreements with other third party providers and certain internal R&D cost allocations. Payments under these agreements include salaries and benefits for R&D personnel, allocated overhead and facility occupancy costs, contract services and other costs. R&D costs are expensed when incurred, except for nonrefundable advance payments for future research and development activities which are capitalized and recognized as expense as the related services are performed. See “Research and Related Agreements” above for disclosure regarding certain terms under our research agreements.

R&D costs decreased during the three and nine months ended May 31, 2013 compared to the three and nine months ended May 31, 2012 due to the phase of technology development associated with the CRADA conducted at the Stevenson-Wydler with the Alliance for Sustainable Energy, LLC, which is the operator of The National Renewable Energy Laboratory under its U.S. Department of Energy contract; and a decrease in R&D costs related to services being performed by Sigma due to prototype fabrication and, an analysis of data and information associated with tested prototypes.

Other Income (Expense)

A summary of our other income (expense) for the three and nine months ended May 31, 2013 and 2012 follows:

	Three Months Ended May 31,					Three Month		Nine Months Ended May 31						Nine Month
	2013		2012			Change		2013			2012			Change
Other income (expense)
Interest expense - other	$	-	$	(8,438	)	$	8,438	$	(30,325	)	$	(8,438	)	$	(21,887	)
Interest expense - accretion of debt discount		-		(15	)		15		(999,485	)		(15	)		(999,470	)
Foreign exchange loss		-		-			-		-			(65	)		65
Payable written off		-		-			-		-			156,109			(156,109	)
Total other income (expense)	$	-	$	(8,453	)	$	8,453	$	(1,029,810	)	$	147,591		$	(1,177,401	)

Interest Expense

“Interest expense – other” relates to the 7% stated interest of the Loan. “Interest expense - accretion of debt discount” also relates to the Loan and represents the accretion of the discount applied to the Loan as a result of the issuance of 625,000 detachable warrants and the beneficial conversion feature contained in the Loan and is calculated according to the effective interest method. As a result of the conversion of the 2012 Promissory Note, the entire balance of the debt discount was recorded as interest expense during 2013.

Liquidity and Capital Resources

The accompanying financial statements have been prepared assuming we will continue as a going concern. We have an accumulated deficit of $16,541,195 as of May 31, 2013. Included in the deficit are non cash expenses totaling $4,570,869 relating to the issuance of stock for services, compensatory stock options, warrants granted for value and accretion of debt discount. Due to the “start-up” nature of our business, we expect to incur losses as we continue development of our photovoltaic and energy harvesting technologies and expand. These conditions raise substantial doubt about our ability to continue as a going concern. Management recognizes that in order for us to meet our capital requirements, and continue to operate, additional financing will likely be necessary. We expect to raise additional funds through private or public equity investment in order to expand the range and scope of business operations. We will seek access to private or public equity but there is no assurance that such additional funds will be available for us to finance our operations on acceptable terms, if at all. If we are unable to raise additional capital or generate positive cash flow, it is unlikely that we will be able to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Our principal source of liquidity is cash in the bank. At May 31, 2013, we had a cash and cash equivalent balance of $715,835. We have financed our operations primarily pursuant to a securities purchase agreement in which we received net proceeds of $3,395,955 in February 2008, from the exercise of warrants and stock options, $1,000,000 of proceeds from the Loan and most recently $1,200,000 from the consummation of a self-directed registered offering of shares and warrants on February 1, 2013.

21

Net cash used in operating activities was $1,537,566 for the nine months ended May 31, 2013, compared to net cash used in operating activities of $1,778,898 for the nine months ended May 31, 2012. Excluding the loss from discontinued operations of $242,210 during the nine months ended May 31, 2012, net cash used in operating activities decreased $878.

Net cash used by investing activities was $0 and $24,458 for the nine months ended May 31, 2013 and 2012, respectively.

Net cash provided by financing activities was $1,206,483 and $1,000,000 for the nine months ended May 31, 2013 and 2012, respectively.

Other Contractual Obligations

In addition to our contractual obligations under the research agreements, as of May 31, 2013, we have future minimum lease payments of $1,341 each month under our corporate and other office operating leases. In addition, we have future minimum payments totaling $13,000 pursuant to agreements with third party providers that we utilize for investor and public relations and marketing and business development.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements.

Recently Issued Accounting Pronouncements

We review new accounting standards as issued. Although some of these accounting standards issued or effective after the end of our previous fiscal year may be applicable to us, we have not identified any standards that we believe merit further discussion. We believe that none of the new standards will have a significant impact on our consolidated financial statements.

Item 4. Controls and Procedures

Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”), as of the end of the period covered by this quarterly report. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that as of May 31, 2013 that our disclosure controls and procedures were effective such that the information required to be disclosed in our United States Securities and Exchange Commission (the “SEC”) reports is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

22

PART II – OTHER INFORMATION

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On February 1, 2013, the Company and 1420524 Alberta Ltd. (the “Creditor”) entered into a Loan Conversion Agreement (“LCA”) whereby the Creditor agreed to convert the entire outstanding balance of the bridge loan the Creditor provided to the Company on April 17, 2012, consisting of $1,000,000 of principal (the “Loan”) and $56,556 of accrued interest payable, into 1,650,869 shares of restricted common stock. In order to induce the Creditor to convert the Loan into shares of common stock, and eliminate the Company’s obligation to repay the Loan in cash, the effective conversion price was reduced to $0.64 (the price at which the Company sold shares pursuant to its self-directed registered offering) from the initial conversion price of $1.60. In addition, as an inducement to convert, the Company issued to the Creditor 825,435 Series H Warrants with an exercise price of $0.83 and three-year term, and reduced the exercise price of the Series G Warrants originally issued in conjunction with the convertible note to $0.64. The Company intends to use the proceeds of the Loan, and any funds received from the exercise of the Series G Warrants and/or Series H Warrants, for general and administrative working purposes. The shares were issued in reliance upon an exemption from registration pursuant to Section 4(2) of the Securities Act.

Item 6. Exhibits

Exhibit No.	Description of Exhibit
10.1	Redacted Modification to the Cooperative Research and Development Agreement entered into between the National Renewable Energy Laboratory and New Energy Technologies, Inc., dated January 16, 2013(1)
10.2	Loan Conversion Agreement dated February 1, 2013, by and between New Energy Technologies, Inc. and 1420524 Alberta Ltd.(2)
10.3	Redacted Letter of Commitment between New Energy Solar Corporation and University of South Florida(3)
31.1	Certification of Principal Executive Officer and Principal Financial Officer Pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
32.1	Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
101.INS	XBRL Instance Document**
101.SCH	XBRL Taxonomy Extension Schema Document**
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document**
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document**
101.LAB	XBRL Taxonomy Extension Label Linkbase Document**
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document**

______________

*Filed herewith

** XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

(1) Incorporated by reference to the Current Report on Form 8-K filed by New Energy Technologies, Inc. on January 22, 2013.

(2) Incorporated by reference to the Current Report on Form 8-K filed by New Energy Technologies, Inc. on February 7, 2013.

(3) Incorporated by reference to the Current Report on Form 8-K filed by New Energy Technologies, Inc. on March 18, 2013.

23

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	New Energy Technologies, Inc. (Registrant)
Date: July 15, 2013	By:	/s/ John A. Conklin
		John A. Conklin
		President and Chief Executive Officer, Chief Financial Officer and Director(Principal Executive Officer, Principal Financial Officer, and Principal Accounting Officer)

24

EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO RULE 13A-14(A) OF THE SECURITIES EXCHANGE ACT OF 1934

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, John A. Conklin, certify that:

1. I have reviewed this quarterly report on Form 10-Q of New Energy Technologies, Inc. (the “Registrant”);

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. As the registrant’s certifying officer I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. As the registrant’s certifying officer I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: July 15, 2013	By:	/s/ John A. Conklin
		John A. Conklin
		President and Chief Executive Officer, Chief Financial Officer and Director

EX-32.1

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the accompanying Quarterly Report on Form 10-Q of New Energy Technologies, Inc. for the fiscal quarter ending May 31, 2013, I, John Conklin, President and Chief Executive Officer and Chief Financial Officer of New Energy Technologies, Inc., hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:

1.   Such Quarterly Report on Form 10-Q for the fiscal quarter ending May 31, 2013, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.   The information contained in such Quarterly Report on Form 10-Q for the fiscal quarter ending May 31, 2013, fairly presents, in all material respects, the financial condition and results of operations of New Energy Technologies, Inc.

Date: July 15, 2013	By:	/s/ John A. Conklin
		John A. Conklin
		President and Chief Executive Officer, Chief Financial Officer and Director

XML

Organization and Going Concern (Details Narrative) (USD $)	9 Months Ended
	May 31, 2013
Organization And Going Concern Details Narrative
Accumulated deficit	$ 16,547,420
Cash and cash equivalents	715,835
Non cash expenses	$ 4,570,869

XML

Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		9 Months Ended		181 Months Ended
	May 31, 2013	May 31, 2012	May 31, 2013	May 31, 2012	May 31, 2013
Consolidated Statements Of Operations
Revenue
Operating expense
Selling, general and administrative	468,166	386,653	2,511,763	1,315,655	13,897,755
Research and development	115,813	241,652	224,490	557,400	2,814,628
Total operating expense	583,979	628,305	2,736,253	1,873,055	16,712,383
Loss from operations	(583,979)	(628,305)	(2,736,253)	(1,873,055)	(16,712,383)
Other income (expense)
Interest income					98,582
Interest expense - other		(8,438)	(30,325)	(8,438)	(68,949)
Interest expense - accretion of debt discount		(15)	(999,485)	(15)	(1,000,000)
Loss on disposal of fixed assets					(5,307)
Gain on dissolution of foreign subsidiary					59,704
Foreign exchange loss				(65)	(86,428)
Change in fair value of warrant liability					2,128,331
Payable written off				156,109	186,109
Total other income (expense)		(8,453)	(1,029,810)	147,591	1,312,042
Loss from continuing operations	(583,979)	(636,758)	(3,766,063)	(1,725,464)	(15,400,341)
Loss from discontinued operations		(3,000)		(242,210)	(404,307)
Net loss	$ (583,979)	$ (639,758)	$ (3,766,063)	$ (1,967,674)	$ (15,804,648)
Basic and Diluted Loss per Common Share:
Continuing operations	$ (0.02)	$ (0.03)	$ (0.17)	$ (0.08)
Discontinued operations				$ (0.01)
Total	$ (0.02)	$ (0.03)	$ (0.17)	$ (0.10)
Weighted average number of common shares outstanding - basic and diluted	24,174,652	20,638,360	22,174,541	20,638,360

XML

Stock Options

9 Months Ended

May 31, 2013

Stock Options

Note 4. Stock Options

On October 10, 2006, the Company’s Board of Directors (the “Board”) adopted and approved the 2006 Incentive Stock Option Plan (the “2006 Stock Plan”) that provides for the grant of stock options to employees, directors, officers and consultants. Stock option grants vest over two to five years and expire ten years after the date of grant. Stockholders previously approved 5,000,000 shares for grant under the 2006 Plan, of which 3,892,495 remain available for grant and 136,667 options have been exercised as of May 31, 2013. All shares approved for grant and subsequently forfeited are available for future grant. The Company does not repurchase shares to fulfill the requirements of options that are exercised. The Company issues new shares when options are exercised.

The Company measures all stock-based compensation based on the fair value on the grant date using the Black-Scholes-Merton formula and recognizes expense over the requisite service period. The Black-Scholes model requires management to make assumptions regarding option time to expiration, expected volatility, and risk-free interest rates, all of which have a significant impact on the fair value of the option.

The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for a bond with a similar term. The Company does not anticipate declaring dividends in the foreseeable future. Volatility is calculated based on the historical closing stock prices. The Company uses the “simplified” method for determining the expected term of its “plain vanilla” stock options. The Company recognizes compensation expense for only the portion of stock options that are expected to vest. Therefore, the Company applies an estimated forfeiture rate that is derived from historical employee termination data and adjusted for expected future employee turnover rates. If the actual number of forfeitures differs from those estimated by the Company, additional adjustments to compensation expense may be required in future periods.

A summary of the Company’s stock option activity for the nine months ended May 31, 2013 and the years ended August 31, 2012 and 2011, and related information follows:

	Number of Options			Weighted Average Exercise Price ($)		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value ($)
Outstanding at August 31, 2010		900,003			1.71
Grants		610,002			5.97
Exercises		(73,334	)		1.61
Forfeitures		(476,666	)		5.59
Outstanding at August 31, 2011		960,005			2.49
Forfeitures		(98,334	)		5.93
Outstanding at August 31, 2012		861,671			2.10
Grants		177,500			1.59
Exercises		(63,333	)		1.65
Forfeitures		(5,000	)		3.27
Outstanding at May 31, 2013		970,838			2.03	7.09 years	$	410,284
Exercisable at May 31, 2013		446,004			2.48	6.47 years	$	164,326
Available for grant at May 31, 2013		3,892,495

The aggregate intrinsic value in the table above represents the total pretax intrinsic value for all “in-the-money” options (i.e. the difference between the Company’s closing stock price on the last trading day of the period covered by this report and the exercise price, multiplied by the number of shares) that would have been received by the option holders had all in-the-money option holders exercised their options on May 31, 2013. The intrinsic value of the option changes based upon the fair market value of the Company’s common stock. Since the closing stock price was $2.11 on May 31, 2013 and 828,335 outstanding options have an exercise price below $2.11 per share, as of May 31, 2013, there is intrinsic value to our outstanding in-the-money stock options.

The following table sets forth the share-based compensation cost resulting from stock option grants, including those previously granted and vesting over time, that were recorded in the Company’s Consolidated Statements of Operations for the three and nine months ended May 31, 2013 and 2012, and from May 5, 1998 (inception) to May 31, 2013:

	Three Months Ended				Nine Months Ended				May 5, 1998
	May 31,				May 31,				(Inception) to
	2013		2012		2013		2012		May 31, 2013
Stock Compensation Expense net of reversals:
Selling general and administrative expense	$	51,165	$	48,272	$	274,731	$	184,942	$	2,405,499

As of May 31, 2013, the Company had $116,828 of unrecognized compensation cost related to unvested stock options which is expected to be recognized over a period of 2.25 years.

Stock Option Activity During the Nine Months Ended May 31, 2013

On December 20, 2012, the Company granted two stock options to purchase up to 15,000 (a 10,000 and 5,000 option grant, respectively) shares of the Company’s common stock at an exercise price of $0.80 per share, the fair market value of the Company’s common stock on the date of grant, to two employees as partial compensation for services. The stock options expire ten years from the date of grant, on December 20, 2022 and vest as follows: (a) 7,500 shares vest immediately on the date of grant and (b) 7,500 shares on the one-year anniversary on December 20, 2013. The stock options are further subject to the terms and conditions of a stock option agreement between the Company and the employees. Under the terms of the stock option agreement, the stock option agreement will terminate and there will be no further vesting of stock options effective as of the date that employees cease to be one of the Company’s employees. Upon termination of such service, the employee will have a specified period of time to exercise vested stock options, if any. The grant date fair value of the stock option granted was $11,700, or $0.78 per option, estimated using the Black-Scholes model containing the following assumptions: Exercise price / spot price of $0.80 per share, dividend yield of 0%, volatility of 160.1%, risk-free rate of 1.14%, and a term of 7.67 years. During the three and nine months ended May 31, 2013, the Company recognized $1,463 and $8,775, respectively of expense related to these two issuances.

On April 27, 2012, pursuant to his employment agreement, the Company’s Vice President of Business and Technology Development, Mr. John Patrick Thompson received a grant of 100,000 stock options. The options have an exercise price of $2.30, the fair market value of the Company’s common stock on the date of grant. The stock options expire ten years from the date of grant, on April 27, 2022 and vest in various amounts upon the meeting of certain milestones and which vesting is subject to Board approval. The stock option is further subject to the terms and conditions of a stock option agreement between the Company and the employee. Under the terms of the stock option agreement, the stock option agreement will terminate and there will be no further vesting of stock options effective as of the date the employee ceases to be one of the Company’s employees. Upon termination of such service, the employee will have a specified period of time to exercise vested stock options, if any. The grant date fair value of the stock option granted was $225,000, or $2.25 per option, estimated using the Black-Scholes model containing the following assumptions: Exercise price / spot price of $2.30 per share, dividend yield of 0%, volatility of 167.1%, risk-free rate of 1.34%, and term of 7.67 years. The Company recognizes compensation cost associated with this stock option grant with performance conditions when the Company determines that it is probable that certain milestones will be achieved. On December 20, 2012, the Company’s Board determined that milestones related to 2,500 options were substantially met and during the three and nine months ended May 31, 2013, the Company recognized $5,625 of expense related to this award.

On January 23, 2013, the Board approved, and the Company granted, a stock option to each of the Company’s four directors, including John Conklin, CEO, to purchase 40,000 shares of its common stock at an exercise price of $1.65 per share, the fair market value of the Company’s common stock on the date of grant. Each stock option expires ten years from the date the applicable stock option agreement was executed, on January 23, 2023, and vests as follows: (a) 20,000 shares vest immediately on the date of grant and (b) 20,000 shares on the one-year anniversary on January 23, 2014. The stock options are further subject to the terms and conditions of a stock option agreement between the Company and each director. Under the terms of the stock option agreement, the stock option agreement will terminate and there will be no further vesting of stock options effective as of the date that the director ceases to be one of the Company’s directors. Upon termination of such service, the director will have a specified period of time to exercise vested stock options, if any. The grant date fair value of each of the stock options granted to each of the Company’s directors was $64,386 estimated using a Black-Scholes model containing the following assumptions: Exercise price / spot price of $1.65 per share, dividend yield of 0%, volatility of 161.1%, risk-free rate of 1.24%, and a term of 7.67 years. During the three and nine months ended May 31, 2013, the Company recognized $32,193 and $193,157 of expense related to this issuance.

On December 10, 2012, Mr. Peter Fusaro resigned from the Board. As a result of his resignation, Mr. Fusaro forfeited 5,000 unvested stock options and had vested 11,667 stock options. Total stock based compensation expense related to Mr. Fusaro’s options was $48,850 of which $44,270 was expensed through August 31, 2012. On November 30, 2012, the Company reversed $10,075 of expense related to forfeited options on which expense was previously recorded resulting in total recognized expense related to Mr. Fusaro’s options of $34,195. Mr. Fusaro has until December 10, 2014, to exercise his 11,667 vested stock options.

Stock Option Activity During the Year Ended August 31, 2012

On December 8, 2011, Mr. Todd Pitcher resigned from the Board. Mr. Pitcher had vested 6,667 stock options and forfeited 10,000 unvested stock options with an exercise price of $3.27 per share. During the year ended August 31, 2011, the Company recorded stock based compensation of $27,784 for the amortization of the fair value of his stock option. Since the stock option was forfeited prior to 10,000 options vesting, $8,243 previously recognized for stock based compensation was reversed on November 30, 2011, resulting in total stock based compensation expense related to Mr. Pitcher’s stock option grant of $19,541. Mr. Pitcher has until December 8, 2013, to exercise his 6,667 vested stock options.

On August 12, 2012, 83,334 vested options with an exercise price of $6.21 per share held by Mr. Andrew Farago, the Company’s former Chief Operating Officer expired unexercised.

On September 30, 2012, Mr. Javier Jimenez resigned from the Board. As a result of his resignation, Mr. Jimenez forfeited 5,000 unvested stock options and had vested 11,667 stock options with an exercise price of $3.27 per share. The Company recorded stock based compensation totaling $91,780 related to the amortization of the fair value of this stock option grant, including the recognition of $66,252 and $25,528 of expense for the years ended August 31, 2012 and 2011, respectively. Since the stock option was forfeited prior to 5,000 options vesting, $23,705 previously recognized for stock based compensation was reversed on August 31, 2012, resulting in total stock based compensation expense related to Mr. Jimenez’s stock option grant of $68,075. Mr. Jimenez has until September 30, 2014, to exercise his 11,667 vested stock options.

The following table summarizes information about stock options outstanding and exercisable at May 31, 2013:

		Stock Options Outstanding						Stock Options Exercisable
				Weighted		Weighted				Weighted Average		Weighted
Range of		Number of		Average		Average		Number		Remaining		Average
Exercise		Options		Contractural		Exercise		of Options		Contractual		Exercise
Prices		Outstanding		Life (years)		Price		Exercisable		Life (Years)		Price
$	0.80		15,000		9.56	$	0.80		7,500		9.56	$	0.80
	1.32		50,001		1.54		1.32		50,001		1.54		1.32
	1.65		763,334		7.07		1.65		250,000		8.61		1.65
	2.30		2,500		8.91		2.30		2,500		8.91		2.30
	2.50		10,000		7.85		2.50		6,000		7.85		2.50
	2.55		33,334		5.28		2.55		33,334		5.28		2.55
	3.27		18,334		1.16		3.27		18,334		1.16		3.27
	4.98		16,667		4.78		4.98		16,667		4.78		4.98
	5.94		50,001		7.57		5.94		50,001		7.57		5.94
	6.51		11,667		1.33		6.51		11,667		1.33		6.51
Total			970,838		7.09	$	2.03		446,004		6.47	$	2.48

XML

Stock Options (Details Narrative) (USD $)		3 Months Ended	9 Months Ended	3 Months Ended	9 Months Ended	3 Months Ended	9 Months Ended	12 Months Ended
	May 31, 2013	May 31, 2013 On December 20, 2012 [Member]	May 31, 2013 On December 20, 2012 [Member]	May 31, 2013 On January 23, 2013 [Member]	May 31, 2013 On January 23, 2013 [Member]	May 31, 2013 On April 27, 2012 [Member]	May 31, 2013 On April 27, 2012 [Member]	Aug. 31, 2012 Javier Jimenez [Member]	Aug. 31, 2011 Javier Jimenez [Member]	Aug. 31, 2011 Todd Pitcher [Member]	Nov. 30, 2011 Todd Pitcher
Unrecognized compensation cost	$ 116,828
Expected period	2 years 3 months
Expense related to issuance		1,463	8,775	32,193	193,157	5,625	5,625
Amortization of the fair value of stock option								66,252	25,528	27,784
Stock based compensation reversed								$ 23,705			$ 8,243

XML

Convertible Promissory Note (Details Narrative) (USD $)	3 Months Ended		9 Months Ended
	May 31, 2013	May 31, 2012	May 31, 2013	May 31, 2012
Convertible Promissory Note Details Narrative
Interest expense related to the 2012 Promissory Note	$ 0	$ 8,438	$ 30,325	$ 8,438
Accretion related to the debt discount	$ 0		$ 999,485

XML

Related Party Transactions (Details Narrative) (USD $)	3 Months Ended		9 Months Ended
	May 31, 2013	May 31, 2012	May 31, 2013	May 31, 2012
Related Party Transactions Details Narrative
Cash based Board compensation	$ 12,750	$ 18,750	$ 40,500	$ 70,350
Stock based compensation expense related to stock options granted non employee	24,983	19,782	151,785	96,138
Legal services	18,550	44,099	84,873	141,528
Accounts payable	$ 6,225		$ 6,225

XML

Net Loss Per Share (Details 1)	3 Months Ended		9 Months Ended
	May 31, 2013	May 31, 2012	May 31, 2013	May 31, 2012
StockOptions [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount	970,838	950,005	970,838	950,005
Warrant [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount	2,380,126	625,000	2,380,126	625,000

XML

Net Loss Per Share (Details) (USD $)	3 Months Ended		9 Months Ended
	May 31, 2013	May 31, 2012	May 31, 2013	May 31, 2012
Numerator:
Loss available to common stockholders	$ (583,979)	$ (639,758)	$ (3,766,063)	$ (1,967,674)
Denominator:
Weighted average number of common shares outstanding	24,174,652	20,638,360	22,174,541	20,638,360
Basic and diluted EPS	$ (0.02)	$ (0.03)	$ (0.17)	$ (0.10)

XML

Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended		181 Months Ended
	May 31, 2013	May 31, 2012	May 31, 2013
Cash flows from operating activities
Loss from continuing operations	$ (3,766,063)	$ (1,725,464)	$ (15,400,342)
Add: loss from discontinued operations		(242,210)	(404,307)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation	4,607	3,883	14,971
Stock based compensation expense	284,806	193,185	7,822,137
Reversal of stock based compensation expense due to forfeiture of stock options	(10,075)	(8,243)	(5,416,638)
Warrants issued to note holder	1,059,038		1,059,038
Change in fair value of warrant liability			(2,128,331)
Loss on disposal of fixed assets			5,307
Payable written off		(156,109)	(186,109)
Common stock issued for services			3,000
Common stock issued for debt settlement			103,332
Accretion of debt discount	999,485	15	1,000,000
Changes in operating assets and liabilities:
Decrease (increase) in deferred research and development costs	(117,405)	70,017	(150,000)
Decrease (increase) in prepaid expenses and other current assets	5,476	53,882	(22,757)
Increase (decrease) in accounts payable	(27,760)	28,608	65,643
Increase (decrease) in accrued liabilities	30,325	3,538	212,665
Net cash used in operating activities	(1,537,566)	(1,778,898)	(13,422,391)
Cash flows from investing activity
Purchase of equipment		(24,458)	(35,637)
Net cash used in investing activity		(24,458)	(35,637)
Cash flows from financing activities
Proceeds from the issuance of common stock, exercise of warrants and stock options, net	1,206,483		13,573,863
Repayment of promissory note			(155,000)
Proceeds from promissory notes		1,000,000	1,155,000
Dividend paid			(400,000)
Net cash provided by financing activities	1,206,483	1,000,000	14,173,863
Increase (decrease) in cash and cash equivalents	(331,083)	(803,356)	715,835
Cash and cash equivalents at beginning of period	1,046,918	2,320,185
Cash and cash equivalents at end of period	715,835	1,516,829	715,835
Supplemental disclosure of cash flow information:
Interest paid in cash			12,393
Income taxes paid in cash
Supplemental disclosure of non-cash transactions:
Accrued management fees converted to equity			103,332
Debt discount recorded for value of warrants issued		547,050	547,050
Debt discount recorded for beneficial conversion feature		452,950	452,950
Warrants issued for broker commissions			642,980
Common stock issued for conversion of note payable	$ 1,056,556		$ 1,056,556

XML

Convertible Promissory Note

9 Months Ended

May 31, 2013

Convertible Promissory Note

Note 2. Convertible Promissory Note

On April 17, 2012, the Company entered into a Bridge Loan Agreement (the “Loan Agreement”) with 1420524 Alberta Ltd. (the “Creditor”), pursuant to which the Company borrowed $1,000,000 at an annual interest rate of 7% (the “Loan”), compounded quarterly; following the occurrence of an event of default, as further specified in the Loan Agreement, the annual interest rate would increase to 15%. The Loan was evidenced by a convertible promissory note with a maturity date of the earlier of: (a) the closing of any equity financing by the Company in excess of $1,000,000, or (b) April 16, 2013 (the “2012 Promissory Note”). As a condition to the Creditor’s entry into the Loan Agreement, the Company issued the Creditor 625,000 Series G Stock Purchase Warrants (the “Series G Warrants”), which are exercisable through April 17, 2015, with an initial exercise price of 84% of the average of the closing price for our common stock as reported on the OTC Markets Group Inc. QB tier (the “OTCQB”) for the five trading days immediately preceding the closing of the Loan, or $1.92 per share, subject to adjustment as provided therein. Additionally, the Series G Warrants contain a cashless exercise provision and require us to file a registration statement with the SEC for the shares issuable upon exercise of the Series G Warrants within 60 days receipt of a written request by the Creditor. According to the original terms of the Loan Agreement, the Creditor could elect, in its sole discretion, to convert all or any portion of the outstanding principal amount of the Loan, and any or all accrued and unpaid interest thereon into shares of our common stock at an initial fixed conversion price equal to seventy (70%) percent of the average of the closing price for the Company’s common stock as reported on the OTCQB for the five trading days immediately preceding the closing of the Loan, or $1.60 per share subject to adjustment as provided therein. The debt discount attributable to the relative fair value of the warrants and the beneficial conversion feature amounted to $547,050 and $452,950, respectively, and was to be accreted over the term of the Loan using the effective interest method.

On February 1, 2013, the Company and the Creditor entered into a Loan Conversion Agreement (“LCA”) whereby the Creditor agreed to convert the entire balance outstanding, including $1,000,000 of principal and $56,556 of accrued interest payable into 1,650,869 shares of restricted common stock. In order to induce the Creditor to convert the Loan into shares of common stock, and eliminate the Company’s obligation to repay the Loan in cash, the effective conversion price was reduced to $0.64 (the price at which the Company sold shares pursuant to its self-directed registered offering; see “NOTE 3 – Stockholders’ Equity (Deficit)” below) from the initial conversion price of $1.60. In addition, as an inducement to convert, the Company issued to the Creditor 825,435 Series H Warrants and reduced the exercise price of the Series G Warrants to $0.64 (See “NOTE 3 – Stockholders’ Equity (Deficit)” below for additional information). No incremental expense was recognized in these consolidated financial statements related to the reduction in the exercise price of the Series G Warrants, and the conversion of the Loan, because the transaction did not meet the requirements for an inducement under accounting principles generally accepted in the United States. As such, the Loan conversion was accounted for as a debt extinguishment with no gain or loss recognized due to the related party nature of the transaction. The Company recognized expense amounting to $1,059,038 for the issuance of the Series H warrants to the Creditor, representing additional financing costs associated with the Loan.

During the three and nine months ended May 31, 2013, the Company recognized $0 and $30,325, respectively, of interest expense related to the 2012 Promissory Note. During the three and nine months ended May 31, 2012, the Company recognized $8,438 of interest expense related to the 2012 Promissory Note.

During the three and nine months ended May 31, 2013, the Company recognized $0 and $999,485, respectively, of accretion related to the Loan discount. As a result of the Loan conversion, the debt discount was fully amortized by February 1, 2013, the date of the LCA.

XML

Net Loss Per Share

9 Months Ended

May 31, 2013

Net Loss Per Share

Note 5. Net Loss Per Share

During the three and nine months ended May 31, 2013 and 2012, the Company recorded a net loss. Basic net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period. The Company has not included the effects of warrants, stock options and convertible debt on net loss per share for the past two fiscal years because to do so would be antidilutive.

Following is the computation of basic and diluted net loss per share for the three and nine months ended May 31, 2013 and 2012:

	Three Months Ended May 31,						Nine Months Ended May 31,
	2013			2012			2013			2012
Basic and Diluted EPS Computation
Numerator:
Loss available to common stockholders'	$	(583,979	)	$	(639,758	)	$	(3,766,063	)	$	(1,967,674	)
Denominator:
Weighted average number of common shares outstanding		24,174,652			20,638,360			22,174,541			20,638,360
Basic and diluted EPS	$	(0.02	)	$	(0.03	)	$	(0.17	)	$	(0.10	)
The shares listed below were not included in the computation of diluted loss per share because to do so would have been antidilutive for the periods presented:
Warrants		2,380,126			625,000			2,380,126			625,000
Stock options		970,838			950,005			970,838			950,005

XML

Stockholders' Equity (Deficit)

9 Months Ended

May 31, 2013

Stockholders Equity Deficit

Note 3. Stockholders' Equity (Deficit)

On February 1, 2013, in full satisfaction of the 2012 Promissory Note, the Company issued to the Creditor 1,650,869 shares of restricted common stock upon the conversion of the 2012 Promissory Note, as adjusted in accordance with the terms of the LCA. Additionally, pursuant to the terms of the LCA, the Company issued to the Creditor 825,435 Series H Warrants and reduced the exercise price of the Series G Warrants to $0.64 (See “Note 2 - Convertible Promissory Note” above for additional information).

On February 1, 2013, the Company completed a self-directed registered offering of 1,875,000 units at a price of $0.64 per unit for $1,200,000 in aggregate proceeds (the “Registered Offering”). Each unit consisted of one share of the Company’s common stock and one-half Series H stock purchase warrant (“Series H Warrant”) to purchase one-half of a share of common stock at the initial exercise price of $0.83 per share for a period of three years from the date of issuance. The Company issued 937,503 Series H Warrants as part of the Registered Offering. The relative fair value of the common stock was estimated to be $638,717 and the relative fair value of the warrants was estimated to be $561,283 as determined based on the relative fair value allocation of the proceeds received. The Series H Warrants were valued using the Black-Scholes option pricing model using the following variables: $0.83 exercise price, $1.48 stock price, 161% volatility, 0.40% risk-free interest rate, 3 year term and no dividends.

On March 21, 2013, the Company issued 7,812 shares of common stock upon the exercise of an equal number of Series H Warrants and received proceeds of $6,484.

Warrants

Each of the Company’s warrants outstanding entitle the holder to purchase one share of the Company’s common stock for each warrant share held. A summary of the Company’s warrants outstanding and exercisable as of May 31, 2013 and August 31, 2012 is as follows:

	Shares of Common Stock Issuable from Warrants Outstanding as of
Description	May 31, 2013		August 31, 2012		Exercise Price		Expiration
Series G		625,000		625,000	$	0.64	April 17, 2015
Series H		1,755,126		-	$	0.83	February 1, 2016
		2,380,126		625,000

The Series G Warrants were issued on April 17, 2012 as a condition to the Creditor entering into the Loan Agreement more fully described above under “Note 2 - Convertible Promissory Note.” In order to induce the Creditor to convert the Loan into shares of the Company’s common stock, the initial exercise price of $1.92 was reduced to $0.64. Additionally, the Series G Warrants contain a cashless exercise provision and registration rights requiring us to file a registration statement with the SEC for the shares issuable upon exercise of the Series G Warrants within 60 days receipt of a written request by the Creditor.

As inducement to convert the Loan, on February 1, 2013, the Company issued to the Creditor 825,435 Series H Warrants (See “Note 2 - Convertible Promissory Note” above for additional information). The warrants have an exercise price of $0.83 per share, expire on the third anniversary of the LCA, or on February 1, 2016 and may be exercised in whole or in part at any time from the date of issuance through expiration. Based on the following Black-Scholes Option Pricing Model assumptions: exercise price - $0.83; market price of common stock - $1.48 per share; estimated volatility - 161%; risk free interest rate - 0.40%; expected dividend rate - 0%; and expected life - 3.0 years, the Company calculated the fair value of these warrants to be $1,059,038.

On February 1, 2013, as part of the Registered Offering, the Company issued 937,503 Series H Warrants (See “Note 3 – Stockholders’ Equity (Deficit)” above for additional information).

During the three and nine months ended May 31, 2013, the Company received $6,484 upon the exercise of 7,812 Series H warrants by two warrant holders.

XML

Consolidated Balance Sheets (Parenthetical) (USD $)	May 31, 2013	Aug. 31, 2012
Current assets
Equipment, accumulated depreciation	$ 10,489	$ 5,882
Current liabilities
Convertible promissory note, discount	$ 0	$ 999,485
Stockholders' equity
Preferred stock, par value	$ 0.10	$ 0.10
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	300,000,000	300,000,000
Common stock, shares issued	24,194,713	20,638,360
Common stock, shares outstanding	24,194,713	20,638,360

XML

Stockholders' Equity (Deficit) (Tables)

9 Months Ended

May 31, 2013

Stockholders Equity Deficit Tables

Warrants outstanding and exercisable

A summary of the Company’s warrants outstanding and exercisable as of May 31, 2013 and August 31, 2012 is as follows:

	Shares of Common Stock Issuable from Warrants Outstanding as of
Description	May 31, 2013		August 31, 2012		Exercise Price		Expiration
Series G		625,000		625,000	$	0.64	April 17, 2015
Series H		1,755,126		-	$	0.83	February 1, 2016
		2,380,126		625,000

XML

Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) (USD $)	Common Stock	Additional Paid-In Capital	Deficit Accumulated During the Development Stage	Total
Beginning Balance, Amount at May. 04, 1998
Restricted common stock issued to related parties for management services at $0.001 per share, Amount	$ 3,000			$ 3,000
Restricted common stock issued to related parties for management services at $0.001 per share, Shares	3,000,000
Unrestricted common stock sales to third parties at $0.40 per share, Amount	375	149,625		150,000
Unrestricted common stock sales to third parties at $0.40 per share, Shares	375,000
Net loss			(12,326)	(12,326)
Ending Balance, Amount at Aug. 31, 1998	3,375	149,625	(12,326)	140,674
Ending Balance, Shares at Aug. 31, 1998	3,375,000
Net loss			(77,946)	(77,946)
Ending Balance, Amount at Aug. 31, 1999	3,375	149,625	(90,272)	62,728
Ending Balance, Shares at Aug. 31, 1999	3,375,000
Net loss			(12,446)	(12,446)
Ending Balance, Amount at Aug. 31, 2000	3,375	149,625	(102,718)	50,282
Ending Balance, Shares at Aug. 31, 2000	3,375,000
Net loss			(12,904)	(12,904)
Ending Balance, Amount at Aug. 31, 2001	3,375	149,625	(115,622)	37,378
Ending Balance, Shares at Aug. 31, 2001	3,375,000
Net loss			(54,935)	(54,935)
Ending Balance, Amount at Aug. 31, 2002	3,375	149,625	(170,557)	(17,557)
Beginning Balance, Shares at Aug. 31, 2002	3,375,000
Restricted common stock issued at $.001 per share to two related parties to satisfy outstanding management fees., Amount	10,333	92,999		103,332
Restricted common stock issued at $.001 per share to two related parties to satisfy outstanding management fees., Shares	10,333,200
Net loss			(97,662)	(97,662)
Ending Balance, Amount at Aug. 31, 2003	13,708	242,624	(268,219)	(11,887)
Ending Balance, Shares at Aug. 31, 2003	13,708,200
Net loss			(19,787)	(19,787)
Ending Balance, Amount at Aug. 31, 2004	13,708	242,624	(288,006)	(31,674)
Ending Balance, Shares at Aug. 31, 2004	13,708,200
Net loss			(103,142)	(103,142)
Ending Balance, Amount at Aug. 31, 2005	13,708	242,624	(391,148)	(134,816)
Beginning Balance, Shares at Aug. 31, 2005	13,708,200
Issuance of common stock and warrants at $0.50 per share, Amount	1,000	499,000		500,000
Issuance of common stock and warrants at $0.50 per share, Shares	1,000,000
Net loss			(157,982)	(157,982)
Ending Balance, Amount at Aug. 31, 2006	14,708	741,624	(549,130)	207,202
Ending Balance, Shares at Aug. 31, 2006	14,708,200
Exercise of Class A Warrants at $0.50 per share, Amount	1,000	499,000		500,000
Exercise of Class A Warrants at $0.50 per share, Shares	1,000,000
Exercise of Class B Warrants at $0.55 per share, Amount	1,000	549,000		550,000
Exercise of Class B Warrants at $0.55 per share, Shares	1,000,000
Exercise of Class C Warrants at $1.50 per share, Amount	327	489,673		490,000
Exercise of Class C Warrants at $1.50 per share, Shares	326,667
Exercise of Class D Warrants at $1.65 per share, Amount	293	483,707		484,000
Exercise of Class D Warrants at $1.65 per share, Shares	293,333
Exercise of Class E Warrants at $1.80 per share, Amount	293	527,707		528,000
Exercise of Class E Warrants at $1.80 per share, Shares	293,333
Issuance of common stock and warrants at $1.50 per share, Amount	333	499,667		500,000
Issuance of common stock and warrants at $1.50 per share, Shares	333,333
Dividend paid - spin off of MircoChannel Technologies Corporation			(400,000)	(400,000)
Net loss			(1,442,769)	(1,442,769)
Ending Balance, Amount at Aug. 31, 2007	17,955	3,790,377	(2,391,899)	1,416,433
Ending Balance, Shares at Aug. 31, 2007	17,954,866
Exercise of Class C Warrants at $1.50 per share, Amount	7	9,993		10,000
Exercise of Class C Warrants at $1.50 per share, Shares	6,667
Exercise of Class D Warrants at $1.65 per share, Amount	7	10,993		11,000
Exercise of Class D Warrants at $1.65 per share, Shares	6,667
Common stock and warrants issued for cash and services at $3.00 per Unit, Amount	1,225	3,394,730		3,395,955
Common stock and warrants issued for cash and services at $3.00 per Unit, Shares	1,225,000
Exercise of Class F Warrants at $3.75 per share, Amount	58	218,692		218,750
Exercise of Class F Warrants at $3.75 per share, Shares	58,333
Stock based compensation		3,600,303		3,600,303
Net loss			(5,721,545)	(5,721,545)
Ending Balance, Amount at Aug. 31, 2008	19,251	11,025,089	(8,113,444)	2,930,896
Ending Balance, Shares at Aug. 31, 2008	19,251,533
Exercise of Class E Warrants at $1.80 per share, Amount	7	11,993		12,000
Exercise of Class E Warrants at $1.80 per share, Shares	6,667
Exercise of Class F Warrants at $3.75 per share, Amount	275	1,032,225		1,032,500
Exercise of Class F Warrants at $3.75 per share, Shares	275,333
Stock based compensation		183,312		183,312
Reversal of stock based compensation due to forfeiture of stock options		(3,591,093)		(3,591,093)
Net loss			1,961,175	1,961,175
Ending Balance, Amount at Aug. 31, 2009	19,533	8,661,526	(6,152,269)	2,528,790
Ending Balance, Shares at Aug. 31, 2009	19,533,533
Stock based compensation		661,040		661,040
Reversal of stock based compensation due to forfeiture of stock options		(478,971)		(478,971)
Cumulative adjustment upon adoption of ASC 815-40		(1,785,560)	(342,771)	(2,128,331)
Net loss			(233,136)	(233,136)
Ending Balance, Amount at Aug. 31, 2010	19,533	7,058,035	(6,728,176)	349,392
Beginning Balance, Shares at Aug. 31, 2010	19,533,533
Exercise of Class F Warrants at $3.75 per share, Amount	1,055	3,953,320		3,954,375
Exercise of Class F Warrants at $3.75 per share, Shares	1,054,512
Stock based compensation		2,855,630		2,855,630
Reversal of stock based compensation due to forfeiture of stock options		(1,304,551)		(1,304,551)
Rounding due to reverse one for three stock split effective March 16, 2011, Amount
Rounding due to reverse one for three stock split effective March 16, 2011, Shares	(3)
Exercise of stock options, Amount	50	30,750		30,800
Exercise of stock options, Shares	50,318
Net loss			(3,619,750)	(3,619,750)
Ending Balance, Amount at Aug. 31, 2011	20,638	12,593,184	(10,347,926)	2,265,896
Ending Balance, Shares at Aug. 31, 2011	20,638,360
Stock based compensation		237,046		237,046
Reversal of stock based compensation due to forfeiture of stock options		(31,948)		(31,948)
Discount on convertible promissory note due to detachable warrants		547,050		547,050
Discount on convertible promissory note due to beneficial conversion feature		452,950		452,950
Net loss			(2,433,431)	(2,433,431)
Ending Balance, Amount at Aug. 31, 2012	20,638	13,798,282	(12,781,357)	1,037,563
Beginning Balance, Shares at Aug. 31, 2012	20,638,360
Stock based compensation		284,806		284,806
Reversal of stock based compensation due to forfeiture of stock options		(10,075)		(10,075)
Exercise of stock options, Amount	22	(22)
Exercise of stock options, Shares	22,672
Issuance of common stock and warrants at $0.64 per unit, Amount	1,875	1,198,125		1,200,000
Issuance of common stock and warrants at $0.64 per unit, Shares	1,875,000
Issuance of common stock upon the conversion of note at $0.64 per share, Amount	1,651	1,054,905		1,056,556
Issuance of common stock upon the conversion of note at $0.64 per share, Shares	1,650,869
Issuance of common stock upon the exercise of Series H Warrants, Amount	8	6,475		6,483
Issuance of common stock upon the exercise of Series H Warrants, Shares	7,812
Expense related to issuance of Series H Warrants as inducement to convert April 17, 2012, $1,000,000 note		1,059,038		1,059,038
Net loss			(3,766,063)	(3,766,063)
Ending Balance, Amount at May. 31, 2013	$ 24,194	$ 17,391,534	$ (16,547,420)	$ 868,308
Ending Balance, Shares at May. 31, 2013	24,194,713

XML

Consolidated Balance Sheets (USD $)	May 31, 2013	Aug. 31, 2012
ASSETS
Cash and cash equivalents	$ 715,835	$ 1,046,918
Deferred research and development costs	150,000	32,595
Prepaid expenses and other current assets	22,757	28,233
Total current assets	888,592	1,107,746
Equipment, net of accumulated depreciation of $10,489 and $5,882, respectively	15,359	19,966
Total assets	903,951	1,127,712
LIABILITIES AND STOCKHOLDERS' EQUITY
Accounts payable	35,643	63,403
Accrued liabilities		26,231
Convertible promissory note, net of discount of $0 and $999,485, respectively		515
Total current liabilities	35,643	90,149
Stockholders' equity
Preferred stock: $0.10 par value; 1,000,000 shares authorized, no shares issued and outstanding at May 31, 2013 and August 31, 2012
Common stock: $0.001 par value; 300,000,000 shares authorized, 24,194,713 and 20,638,360 shares issued and outstanding at May 31, 2013 and August 31, 2012, respectively	24,194	20,638
Additional paid-in capital	17,391,534	13,798,282
Deficit accumulated during the development stage	(16,547,420)	(12,781,357)
Total stockholders' equity	868,308	1,037,563
Total liabilities and stockholders' equity	$ 903,951	$ 1,127,712

XML

Stock Options (Details 2) (USD $)	9 Months Ended
	May 31, 2013
Number of options outstanding	970,838
Weighted average contractural life (years)	7 years 1 month 2 days
Weighted-average exercise price	$ 2.03
Number of options exercisable	446,004
Weighted average contractural life (years) of options exercisable	6 years 5 months 19 days
Weighted-average exercise price of options exercisable	$ 2.48
$ 0.80 Per Share [Member]
Number of options outstanding	15,000
Weighted average contractural life (years)	9 years 6 months 22 days
Weighted-average exercise price	$ 0.80
Number of options exercisable	7,500
Weighted average contractural life (years) of options exercisable	9 years 6 months 22 days
Weighted-average exercise price of options exercisable	$ 0.80
$ 1.32 Per Share [Member]
Number of options outstanding	50,001
Weighted average contractural life (years)	1 year 6 months 15 days
Weighted-average exercise price	$ 1.32
Number of options exercisable	50,001
Weighted average contractural life (years) of options exercisable	1 year 9 months 14 days
Weighted-average exercise price of options exercisable	$ 1.32
$ 1.65 Per Share [Member]
Number of options outstanding	763,334
Weighted average contractural life (years)	7 years 26 days
Weighted-average exercise price	$ 1.65
Number of options exercisable	250,000
Weighted average contractural life (years) of options exercisable	8 years 7 months 10 days
Weighted-average exercise price of options exercisable	$ 1.65
$ 2.30 Per Share [Member]
Number of options outstanding	2,500
Weighted average contractural life (years)	8 years 10 months 28 days
Weighted-average exercise price	$ 2.30
Number of options exercisable	2,500
Weighted average contractural life (years) of options exercisable	8 years 10 months 28 days
Weighted-average exercise price of options exercisable	$ 2.30
$ 2.50 Per Share [Member]
Number of options outstanding	10,000
Weighted average contractural life (years)	7 years 6 months
Weighted-average exercise price	$ 2.50
Number of options exercisable	6,000
Weighted average contractural life (years) of options exercisable	7 years 6 months
Weighted-average exercise price of options exercisable	$ 2.50
$ 2.55 Per Share [Member]
Number of options outstanding	33,334
Weighted average contractural life (years)	5 years 3 months 11 days
Weighted-average exercise price	$ 2.55
Number of options exercisable	33,334
Weighted average contractural life (years) of options exercisable	5 years 3 months 11 days
Weighted-average exercise price of options exercisable	$ 2.55
$ 3.27 Per Share [Member]
Number of options outstanding	18,334
Weighted average contractural life (years)	1 year 1 month 28 days
Weighted-average exercise price	$ 3.27
Number of options exercisable	18,334
Weighted average contractural life (years) of options exercisable	1 year 1 month 28 days
Weighted-average exercise price of options exercisable	$ 3.27
$ 4.98 Per Share [Member]
Number of options outstanding	16,667
Weighted average contractural life (years)	4 years 9 months 11 days
Weighted-average exercise price	$ 4.98
Number of options exercisable	16,667
Weighted average contractural life (years) of options exercisable	4 years 9 months 11 days
Weighted-average exercise price of options exercisable	$ 4.98
$ 5.94 Per Share [Member]
Number of options outstanding	50,001
Weighted average contractural life (years)	7 years 6 months 26 days
Weighted-average exercise price	$ 5.94
Number of options exercisable	50,001
Weighted average contractural life (years) of options exercisable	7 years 6 months 26 days
Weighted-average exercise price of options exercisable	$ 5.94
$ 6.51 Per Share [Member]
Number of options outstanding	11,677
Weighted average contractural life (years)	1 year 3 months 29 days
Weighted-average exercise price	$ 6.51
Number of options exercisable	11,667
Weighted average contractural life (years) of options exercisable	1 year 3 months 29 days
Weighted-average exercise price of options exercisable	$ 6.51

XML

Organization and Going Concern (Policies)

9 Months Ended

May 31, 2013

Organization And Going Concern Policies

Basis of Presentation

The unaudited financial statements of New Energy Technologies, Inc. as of May 31, 2013, and for the three and nine months ended May 31, 2013 and 2012, have been prepared in accordance with accounting principles generally accepted in the United States for interim financial reporting. Accordingly, they do not include all of the disclosures required by accounting principles generally accepted in the United States for complete financial statements and should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended August 31, 2012, as filed with the Securities and Exchange Commission as part of the Company’s Form 10-K. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of the interim financial information have been included. The results of operations for any interim period are not necessarily indicative of the results of operations for the entire year.

Organization

New Energy Technologies, Inc. (the “Company”) was incorporated in the State of Nevada on May 5, 1998, under the name “Octillion Corp.” On December 2, 2008, the Company amended its Articles of Incorporation to effect a change of name to New Energy Technologies, Inc. The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Sungen Energy, Inc. (“Sungen”), Kinetic Energy Corporation (“KEC”), and New Energy Solar Corporation (“New Energy Solar”).

Sungen was incorporated on July 11, 2006, in the State of Nevada and is currently inactive.

KEC was incorporated on June 19, 2008, in the State of Nevada and holds the patents related to the Company’s MotionPower™ Technology. The Company’s business activities related to the MotionPower™ Technology are conducted through KEC.

New Energy Solar was incorporated on February 9, 2009, in the State of Florida and has entered into agreements with the University of South Florida Research Foundation, Inc. to sponsor research related to the Company’s SolarWindow™ Technology.

On March 16, 2011, pursuant to a consent signed by the Company’s shareholders owning more than 50% of the Company’s issued and outstanding shares of common stock, the Company filed a Certificate of Amendment to its Certificate of Incorporation increasing its authorized shares of common stock, $0.001 par value, from 100,000,000 to 300,000,000.

On August 19, 2011, the Company established Nakoda Energy, Inc., a California corporation and wholly-owned subsidiary of the Company, which began operations in September 2011. Nakoda is an energy savings and management corporation that provides a broad range of energy solutions and savings projects with the goal of implementing energy conservation, load management, and reducing building energy consumption in target markets. Due to the high costs associated with growing operations and difficult financing environment, management suspended all Nakoda related operations as of November 30, 2011. On January 20, 2012, management completed the sale of Nakoda Energy, Inc. pursuant to a stock purchase agreement. The Company did not recognize any revenue from Nakoda related operations nor were there any recorded assets or liabilities as of and during the periods presented.

The Company is a renewable and alternative energy company, actively developing two novel technologies for generating sustainable electricity, one of which collects light energy from the sun and artificial sources (SolarWindow™), and the other harvests kinetic energy present in moving vehicles (MotionPower™). The Company’s proprietary, patent-pending technologies and products, which are the subjects of sixty-six (66) patent-filings, have been invented, designed, engineered, and prototyped in preparation for further field testing, product development, and eventual commercial deployment.

The Company’s SolarWindow™ Technology generates electrical energy when the electricity-generating coating is applied to glass and plastic surfaces, creating, semi-transparent, see-through solar cells. If successfully developed, SolarWindow™ could potentially be used on any of the more than 85 million commercial and residential buildings in the United States alone (U.S. Census Bureau, 2007 American Housing Survey & U.S. Energy Information Administration, 2003 Commercial Buildings Energy Consumption Survey). The Company has filed seven (7) new Patent related to the SolarWindow™ Technology since our last 10-Q filing. The Company’s SolarWindow™ Technology is the subject of a total of twenty-one (21) patent filings.

The Company’s MotionPower™ Technology harvests, or captures, the “kinetic” or “motion” energy of cars, trucks, buses, and heavy commercial vehicles when they pass over the system or slow down before coming to a stop. MotionPower™ converts this captured energy into electricity. If successfully developed, MotionPower™ could potentially be used to harvest kinetic energy generated by any of the estimated 250 million vehicles registered in America (U.S. Department of Transportation Federal Highway Administration, 2008 Highway Statistics), which drive approximately six billion miles on our nation’s roadways every day (U.S. Environmental Protection Agency). The Company’s MotionPower™ Technology is the subject of forty-five (45) patent filings.

The Company’s product development programs involve ongoing research and development efforts, and the commitment of significant resources to support the extensive invention, design, engineering, testing, prototyping, and intellectual property initiatives carried-out by its contract engineers, scientists, and consultants.

The Company continues to assess the ongoing development and value propositions of its novel SolarWindow™ and MotionPower™ technologies. This assessment helps us strategically focus on specific technology development which best delivers significant long-term commercial competitive advantages.

Going Concern

The Company is a development stage company, does not have any commercialized products and has not generated any revenue since inception. The Company has an accumulated deficit of $16,547,420 as of May 31, 2013, and does not have positive cash flows from operating activities. Included in the deficit are non cash expenses totaling $4,570,869 relating to the issuance of stock for services, compensatory stock options, warrants granted for value and accretion of debt discount. The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America, which contemplates continuation of the Company as a going concern, which is dependent upon the Company’s ability to establish itself as a profitable business.

In its report with respect to the Company’s financial statements for the year ended August 31, 2012, the Company’s independent auditors expressed substantial doubt about the Company’s ability to continue as a going concern. Because the Company has not yet generated revenues from its operations and does not expect to do so in the near future, its ability to continue as a going concern is wholly dependent upon its ability to obtain additional financing.

On February 1, 2013, the Company received $1,200,000 from an equity financing through the sale of its securities. As of May 31, 2013, the Company had cash and cash equivalents of $715,835. The Company will remain engaged in research and product development activities at least through January 2015. Based upon its current and near term anticipated level of operations and expenditures, the Company believes that, absent any modification or expansion of its existing research, development and testing activities, cash on hand should be sufficient to enable it to continue operations through October 2013. However, any significant expansion in scope or acceleration in timing of the Company’s current research and development activities, or commencement of any marketing, and public and investor relations activities, will require additional funds.

If adequate funds are not available on reasonable terms, or at all, it would result in a material adverse effect on the Company’s business, operating results, financial condition and prospects. In particular, the Company may be required to delay, reduce the scope of or terminate one or more of its research programs, sell rights to its SolarWindow™ Technology and/or MotionPowerTM Technology or other technologies or products based upon such technologies, or license the rights to such technologies or products on terms that are less favorable to the Company than might otherwise be available.

In view of these conditions, the ability of the Company to continue as a going concern is in substantial doubt and dependent upon achieving a profitable level of operations and on the ability of the Company to obtain necessary financing to fund ongoing operations. These consolidated financial statements do not give effect to any adjustments which will be necessary should the Company be unable to continue as a going concern and therefore be required to realize its assets and discharge its liabilities in other than the normal course of business and at amounts different from those reflected in the accompanying consolidated financial statements

XML

Net Loss Per Share (Tables)

9 Months Ended

May 31, 2013

Net Loss Per Share Tables

Computation of basic and diluted net loss per share

Following is the computation of basic and diluted net loss per share for the three and nine months ended May 31, 2013 and 2012:

	Three Months Ended May 31,						Nine Months Ended May 31,
	2013			2012			2013			2012
Basic and Diluted EPS Computation
Numerator:
Loss available to common stockholders'	$	(583,979	)	$	(639,758	)	$	(3,766,063	)	$	(1,967,674	)
Denominator:
Weighted average number of common shares outstanding		24,174,652			20,638,360			22,174,541			20,638,360
Basic and diluted EPS	$	(0.02	)	$	(0.03	)	$	(0.17	)	$	(0.10	)

Antidilutive Securities Excluded From Computation Of Earnings Per Share

The shares listed below were not included in the computation of diluted loss per share because to do so would have been antidilutive for the periods presented:
Warrants	2,380,126	625,000	2,380,126	625,000
Stock options	970,838	950,005	970,838	950,005

XML

Related Party Transactions

9 Months Ended

May 31, 2013

Related Party Transactions

Note 6. Related Party Transactions

A related party is generally defined as (i) any person that holds 10% or more of the Company’s securities and their immediate families, (ii) the Company’s management, (iii) someone that directly or indirectly controls, is controlled by or is under common control with the Company, or (iv) anyone who can significantly influence the financial and operating decisions of the Company. A transaction is considered to be a related party transaction when there is a transfer of resources or obligations between related parties.

For services rendered in the capacity of a Board member, non-employee Board members received $3,750 per quarter through the quarter ended February 28, 2013. The amount was increased to $4,250 per quarter beginning with the current quarter ending on May 31, 2013. New Board member compensation is pro rated in their first quarter. During the three months ended May 31, 2013 and 2012, the Company incurred $12,750 and $18,750, respectively in cash based Board compensation. During the nine months ended May 31, 2013 and 2012, the Company incurred $40,500 and $70,350, respectively in cash based Board compensation. Additionally, the Company recognized stock compensation expense related to stock options granted for services rendered by non-employee directors of the Company, which is included in professional fees (See “Note 4 - Stock Options” above) during the three months ended May 31, 2013 and 2012 of $24,983 and $19,782, respectively. During the nine months ended May 31, 2013 and 2012, the Company recognized stock compensation expense of $151,785 and $96,138, respectively.

The law firm of Sierchio & Company, LLP, of which Joseph Sierchio, one of the Company's directors, is a principal, has provided counsel to the Company since its inception. In July 2008, the Company asked Mr. Sierchio to join the Company’s Board. During the three months ended May 31, 2013 and 2012, the law firm of Sierchio & Company, LLP provided $18,550 and $44,099, respectively, of legal services. During the nine months ended May 31, 2013 and 2012, the law firm of Sierchio & Company, LLP provided $84,873 and $141,528, respectively, of legal services. At May 31, 2013, the Company owed Sierchio & Company LLP $6,225 which is included in accounts payable.

On February 1, 2013, Kalen Capital Holdings LLC, a wholly-owned subsidiary of Kalen Capital Corporation, a shareholder owning in excess of 5% of the Company’s issued and outstanding stock, purchased 1,843,748 shares of the Company’s common stock and 921,875 Series H Warrants for an aggregate purchase price of $1,180,000 pursuant to the registered public offering conducted by the Company (See “NOTE 3 – Stockholders’ Equity (Deficit)” above).

All related party transactions are recorded at the exchange amount established and agreed to between related parties and are in the normal course of business.

XML

Organization and Going Concern

9 Months Ended

May 31, 2013

Organization And Going Concern

Note 1. Organization and Going Concern

Basis of Presentation

The unaudited financial statements of New Energy Technologies, Inc. as of May 31, 2013, and for the three and nine months ended May 31, 2013 and 2012, have been prepared in accordance with accounting principles generally accepted in the United States for interim financial reporting. Accordingly, they do not include all of the disclosures required by accounting principles generally accepted in the United States for complete financial statements and should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended August 31, 2012, as filed with the Securities and Exchange Commission as part of the Company’s Form 10-K. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of the interim financial information have been included. The results of operations for any interim period are not necessarily indicative of the results of operations for the entire year.

Organization

New Energy Technologies, Inc. (the “Company”) was incorporated in the State of Nevada on May 5, 1998, under the name “Octillion Corp.” On December 2, 2008, the Company amended its Articles of Incorporation to effect a change of name to New Energy Technologies, Inc. The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Sungen Energy, Inc. (“Sungen”), Kinetic Energy Corporation (“KEC”), and New Energy Solar Corporation (“New Energy Solar”).

Sungen was incorporated on July 11, 2006, in the State of Nevada and is currently inactive.

KEC was incorporated on June 19, 2008, in the State of Nevada and holds the patents related to the Company’s MotionPower™ Technology. The Company’s business activities related to the MotionPower™ Technology are conducted through KEC.

New Energy Solar was incorporated on February 9, 2009, in the State of Florida and has entered into agreements with the University of South Florida Research Foundation, Inc. to sponsor research related to the Company’s SolarWindow™ Technology.

On March 16, 2011, pursuant to a consent signed by the Company’s shareholders owning more than 50% of the Company’s issued and outstanding shares of common stock, the Company filed a Certificate of Amendment to its Certificate of Incorporation increasing its authorized shares of common stock, $0.001 par value, from 100,000,000 to 300,000,000.

On August 19, 2011, the Company established Nakoda Energy, Inc., a California corporation and wholly-owned subsidiary of the Company, which began operations in September 2011. Nakoda is an energy savings and management corporation that provides a broad range of energy solutions and savings projects with the goal of implementing energy conservation, load management, and reducing building energy consumption in target markets. Due to the high costs associated with growing operations and difficult financing environment, management suspended all Nakoda related operations as of November 30, 2011. On January 20, 2012, management completed the sale of Nakoda Energy, Inc. pursuant to a stock purchase agreement. The Company did not recognize any revenue from Nakoda related operations nor were there any recorded assets or liabilities as of and during the periods presented.

The Company is a renewable and alternative energy company, actively developing two novel technologies for generating sustainable electricity, one of which collects light energy from the sun and artificial sources (SolarWindow™), and the other harvests kinetic energy present in moving vehicles (MotionPower™). The Company’s proprietary, patent-pending technologies and products, which are the subjects of sixty-six (66) patent-filings, have been invented, designed, engineered, and prototyped in preparation for further field testing, product development, and eventual commercial deployment.

The Company’s SolarWindow™ Technology generates electrical energy when the electricity-generating coating is applied to glass and plastic surfaces, creating, semi-transparent, see-through solar cells. If successfully developed, SolarWindow™ could potentially be used on any of the more than 85 million commercial and residential buildings in the United States alone (U.S. Census Bureau, 2007 American Housing Survey & U.S. Energy Information Administration, 2003 Commercial Buildings Energy Consumption Survey). The Company has filed seven (7) new Patent related to the SolarWindow™ Technology since our last 10-Q filing. The Company’s SolarWindow™ Technology is the subject of a total of twenty-one (21) patent filings.

The Company’s MotionPower™ Technology harvests, or captures, the “kinetic” or “motion” energy of cars, trucks, buses, and heavy commercial vehicles when they pass over the system or slow down before coming to a stop. MotionPower™ converts this captured energy into electricity. If successfully developed, MotionPower™ could potentially be used to harvest kinetic energy generated by any of the estimated 250 million vehicles registered in America (U.S. Department of Transportation Federal Highway Administration, 2008 Highway Statistics), which drive approximately six billion miles on our nation’s roadways every day (U.S. Environmental Protection Agency). The Company’s MotionPower™ Technology is the subject of forty-five (45) patent filings.

The Company’s product development programs involve ongoing research and development efforts, and the commitment of significant resources to support the extensive invention, design, engineering, testing, prototyping, and intellectual property initiatives carried-out by its contract engineers, scientists, and consultants.

The Company continues to assess the ongoing development and value propositions of its novel SolarWindow™ and MotionPower™ technologies. This assessment helps us strategically focus on specific technology development which best delivers significant long-term commercial competitive advantages.

Going Concern

The Company is a development stage company, does not have any commercialized products and has not generated any revenue since inception. The Company has an accumulated deficit of $16,547,420 as of May 31, 2013, and does not have positive cash flows from operating activities. Included in the deficit are non cash expenses totaling $4,570,869 relating to the issuance of stock for services, compensatory stock options, warrants granted for value and accretion of debt discount. The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America, which contemplates continuation of the Company as a going concern, which is dependent upon the Company’s ability to establish itself as a profitable business.

In its report with respect to the Company’s financial statements for the year ended August 31, 2012, the Company’s independent auditors expressed substantial doubt about the Company’s ability to continue as a going concern. Because the Company has not yet generated revenues from its operations and does not expect to do so in the near future, its ability to continue as a going concern is wholly dependent upon its ability to obtain additional financing.

On February 1, 2013, the Company received $1,200,000 from an equity financing through the sale of its securities. As of May 31, 2013, the Company had cash and cash equivalents of $715,835. The Company will remain engaged in research and product development activities at least through January 2015. Based upon its current and near term anticipated level of operations and expenditures, the Company believes that, absent any modification or expansion of its existing research, development and testing activities, cash on hand should be sufficient to enable it to continue operations through October 2013. However, any significant expansion in scope or acceleration in timing of the Company’s current research and development activities, or commencement of any marketing, and public and investor relations activities, will require additional funds.

If adequate funds are not available on reasonable terms, or at all, it would result in a material adverse effect on the Company’s business, operating results, financial condition and prospects. In particular, the Company may be required to delay, reduce the scope of or terminate one or more of its research programs, sell rights to its SolarWindow™ Technology and/or MotionPowerTM Technology or other technologies or products based upon such technologies, or license the rights to such technologies or products on terms that are less favorable to the Company than might otherwise be available.

In view of these conditions, the ability of the Company to continue as a going concern is in substantial doubt and dependent upon achieving a profitable level of operations and on the ability of the Company to obtain necessary financing to fund ongoing operations. These consolidated financial statements do not give effect to any adjustments which will be necessary should the Company be unable to continue as a going concern and therefore be required to realize its assets and discharge its liabilities in other than the normal course of business and at amounts different from those reflected in the accompanying consolidated financial statements.

XML

Stockholders' Equity (Deficit) (Details) (USD $)	May 31, 2013	Aug. 31, 2012
Shares of Common Stock Issuable from Warrants	2,380,126	625,000
Series G [Member]
Shares of Common Stock Issuable from Warrants	625,000	625,000
Exercise Price	$ 0.64
Expiration	Apr. 17, 2015
Series H [Member]
Shares of Common Stock Issuable from Warrants	1,755,126
Exercise Price	$ 0.83
Expiration	Feb. 01, 2016

XML

Stock Options (Tables)

9 Months Ended

May 31, 2013

Stock Options Tables

Stock option activity

A summary of the Company’s stock option activity for the nine months ended May 31, 2013 and the years ended August 31, 2012 and 2011, and related information follows:

	Number of Options			Weighted Average Exercise Price ($)		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value ($)
Outstanding at August 31, 2010		900,003			1.71
Grants		610,002			5.97
Exercises		(73,334	)		1.61
Forfeitures		(476,666	)		5.59
Outstanding at August 31, 2011		960,005			2.49
Forfeitures		(98,334	)		5.93
Outstanding at August 31, 2012		861,671			2.10
Grants		177,500			1.59
Exercises		(63,333	)		1.65
Forfeitures		(5,000	)		3.27
Outstanding at May 31, 2013		970,838			2.03	7.09 years	$	410,284
Exercisable at May 31, 2013		446,004			2.48	6.47 years	$	164,326
Available for grant at May 31, 2013		3,892,495

Share-based compensation cost

The following table sets forth the share-based compensation cost resulting from stock option grants, including those previously granted and vesting over time, that were recorded in the Company’s Consolidated Statements of Operations for the three and nine months ended May 31, 2013 and 2012, and from May 5, 1998 (inception) to May 31, 2013:

	Three Months Ended				Nine Months Ended				May 5, 1998
	May 31,				May 31,				(Inception) to
	2013		2012		2013		2012		May 31, 2013
Stock Compensation Expense net of reversals:
Selling general and administrative expense	$	51,165	$	48,272	$	274,731	$	184,942	$	2,405,499

Stock options outstanding and exercisable

The following table summarizes information about stock options outstanding and exercisable at May 31, 2013:

		Stock Options Outstanding						Stock Options Exercisable
				Weighted		Weighted				Weighted Average		Weighted
Range of		Number of		Average		Average		Number		Remaining		Average
Exercise		Options		Contractural		Exercise		of Options		Contractual		Exercise
Prices		Outstanding		Life (years)		Price		Exercisable		Life (Years)		Price
$	0.80		15,000		9.56	$	0.80		7,500		9.56	$	0.80
	1.32		50,001		1.54		1.32		50,001		1.54		1.32
	1.65		763,334		7.07		1.65		250,000		8.61		1.65
	2.30		2,500		8.91		2.30		2,500		8.91		2.30
	2.50		10,000		7.85		2.50		6,000		7.85		2.50
	2.55		33,334		5.28		2.55		33,334		5.28		2.55
	3.27		18,334		1.16		3.27		18,334		1.16		3.27
	4.98		16,667		4.78		4.98		16,667		4.78		4.98
	5.94		50,001		7.57		5.94		50,001		7.57		5.94
	6.51		11,667		1.33		6.51		11,667		1.33		6.51
Total			970,838		7.09	$	2.03		446,004		6.47	$	2.48

XML

Stock Options (Details 1) (Selling, General and Administrative Expenses [Member], USD $)	3 Months Ended		9 Months Ended		181 Months Ended
	May 31, 2013	May 31, 2012	May 31, 2013	May 31, 2012	May 31, 2013
Selling, General and Administrative Expenses [Member]
Stock Compensation Expense:
Share-based compensation cost	$ 51,165	$ 48,272	$ 274,731	$ 184,942	$ 2,405,499

XML

Stockholders' Equity (Deficit) (Details Narrative) (USD $)	3 Months Ended	9 Months Ended
	May 31, 2013	May 31, 2013
Stockholders Equity Deficit Details Narrative
Series H warrants exercised	7,812	7,812
Cash received from excercised of series H warrants	$ 6,484	$ 6,484

XML

Document and Entity Information	9 Months Ended
	May 31, 2013	Jul. 15, 2013
Document And Entity Information
Entity Registrant Name	NEW ENERGY TECHNOLOGIES, INC.
Entity Central Index Key	0001071840
Document Type	10-Q
Document Period End Date	May 31, 2013
Amendment Flag	false
Current Fiscal Year End Date	--08-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		24,194,713
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2013

XML

Stock Options (Details) (USD $)	9 Months Ended	12 Months Ended
	May 31, 2013	Aug. 31, 2012	Aug. 31, 2011
Number of Options
Outstanding Beginning	861,671	960,005	900,003
Grants	177,500		610,002
Exercises	(63,333)		(73,334)
Forfeitures	(5,000)	(98,334)	(476,666)
Outstanding Ending	970,838	861,671	960,005
Exercisable at May 31, 2013	446,004
Available for grant at May 31, 2013	3,892,495
Weighted Average Exercise Price ($)
Weighted-average exercise price	$ 2.10	$ 2.49	$ 1.71
Grants	$ 1.59		$ 5.97
Exercises	$ 1.65		$ 1.61
Forfeitures	$ 3.27	$ 5.93	$ 5.59
Weighted-average exercise price	$ 2.03	$ 2.10	$ 2.49
Exercisable at May 31, 2013	$ 2.48
Weighted Average Remaining Contractual Term
Outstanding at May 31, 2013	7 years 1 month 2 days
Exercisable at May 31, 2013	6 years 5 months 19 days
Aggregate Intrinsic Value ($)
Outstanding at May 31, 2013	$ 410,284
Exercisable at May 31, 2013	$ 164,326